+关注
Annie12345
暂无个人介绍
IP属地:未知
614
关注
42
粉丝
0
主题
0
勋章
主贴
热门
Annie12345
2021-12-14
Yea
外媒头条:美联储可能上演历史罕见鹰派转变
Annie12345
2021-12-13
Ok
@Deonc:Sea Limited drops to end week
Annie12345
2021-12-13
O
@问就是加仓up:2021年复盘:大赚到接近清零,回本绝对是最浪漫的事
Annie12345
2021-12-01
Hopefully today turn green
Oversold Singapore Bourse Called Lower Again
Annie12345
2021-11-27
Ok
@FundMall:Fund College: When should you take profit?
Annie12345
2021-11-27
O
Dow plunges 905 points in Black Friday selloff, books worst day in over a year as WHO declares new COVID 'variant of concern'
Annie12345
2021-11-27
Haiz
Dow plunges 905 points in Black Friday selloff, books worst day in over a year as WHO declares new COVID 'variant of concern'
Annie12345
2021-11-21
Lol
UBS Picks Former Morgan Stanley President Kelleher As chairman, Deutsche Bank Nominates Alexander Wynaendts As Next Chairman
Annie12345
2021-11-14
like
Apple: The Bear Argument, And Why It's Wrong
Annie12345
2021-11-13
Like
Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.
Annie12345
2021-11-12
Like
Goldman Sachs builds thematic ETF lineup with three new disruptive funds
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3573948076022422","uuid":"3573948076022422","gmtCreate":1610893425069,"gmtModify":1704447516716,"name":"Annie12345","pinyin":"annie12345","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/b7529e308acffa5522a9e9690d9dcae6","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":42,"headSize":614,"tweetSize":11,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.48%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.06.02","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.04%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":604455354,"gmtCreate":1639441217413,"gmtModify":1639441217858,"author":{"id":"3573948076022422","authorId":"3573948076022422","name":"Annie12345","avatar":"https://static.tigerbbs.com/b7529e308acffa5522a9e9690d9dcae6","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573948076022422","authorIdStr":"3573948076022422"},"themes":[],"htmlText":"Yea ","listText":"Yea ","text":"Yea","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604455354","repostId":"2191098415","repostType":2,"repost":{"id":"2191098415","pubTimestamp":1639431600,"share":"https://www.laohu8.com/m/news/2191098415?lang=&edition=full","pubTime":"2021-12-14 05:40","market":"hk","language":"zh","title":"外媒头条:美联储可能上演历史罕见鹰派转变","url":"https://stock-news.laohu8.com/highlight/detail?id=2191098415","media":"市场资讯","summary":" 纽约联邦储备银行最新消费者调查显示,美国消费者对未来一年的通胀预期升至6%的新高。 这一结果凸显出近期令美联储和大多数经济学家感到意外的通胀飙升的不可预测性。美联储可能在即将召开的政策会议上宣布加快减码债券收购的步伐。 经济学家预计,美联储官员本周将加快收缩购债步伐,并发出2022年加息的信号,在1980年代以来最强通胀面前上演历史性的政策转变。","content":"<p><b>全球财经媒体昨夜今晨共同关注的头条新闻主要有:</b></p>\n<blockquote>\n <b>1、纽约联储调查显示:消费者对未来一年的通胀预期升至6%的新高</b>\n</blockquote>\n<blockquote>\n <b>2、加速减码+预告加息 美联储可能上演历史罕见的鹰派转变</b>\n</blockquote>\n<blockquote>\n <b>3、<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>CEO埃隆·马斯克当选时代杂志2021年度风云人物</b>\n</blockquote>\n<blockquote>\n <b>4、牛津大学:omicron毒株能削弱两针<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>或<a href=\"https://laohu8.com/S/AZN\">阿斯利康</a>疫苗的保护力</b>\n</blockquote>\n<blockquote>\n <b>5、七国集团财长承诺解决供应链问题并避免未来重演</b>\n</blockquote>\n<blockquote>\n <b>6、小摩预计美失业率明年将降至3%左右 奥密克戎是就业市场主要风险</b>\n</blockquote>\n<p><img src=\"https://static.tigerbbs.com/ce56c82d6c11f45604012124909fbdc4\" tg-width=\"550\" tg-height=\"313\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p><b>纽约联储调查显示:消费者对未来一年的通胀预期升至6%的新高</b></p>\n<p>纽约联邦储备银行最新消费者调查显示,美国消费者对未来一年的通胀预期升至6%的新高。</p>\n<p>调查还显示,三年通胀预期自6月以来首次下降,达到4%,主要是受到无大学学历受访者的预期推动。然而,无论是短期还是长期,通胀的不确定性水平都在上升,并且都达到了历史新高。</p>\n<p>这一结果凸显出近期令美联储和大多数经济学家感到意外的通胀飙升的不可预测性。美联储可能在即将召开的政策会议上宣布加快减码债券收购的步伐。</p>\n<p>调查还显示,消费者对经济的乐观程度下降。</p>\n<p>调查显示,美国未来一年失业率上升的平均概率提高了0.6个百分点。11月受访者对与一年前相比家庭当前财务状况的看法有所恶化,更多受访者称财务状况变差。</p>\n<p><img src=\"https://static.tigerbbs.com/ad8e2ae248c8736422a112e3a316d6b9\" tg-width=\"550\" tg-height=\"310\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p><b>加速减码+预告加息 美联储可能上演历史罕见的鹰派转变</b></p>\n<p>经济学家预计,美联储官员本周将加快收缩购债步伐,并发出2022年加息的信号,在1980年代以来最强通胀面前上演历史性的政策转变。</p>\n<p>超过一半的受访者预计,美联储周三结束两天政策会议后发布的季度预测将显示,18位官员的中值预测是明年加息两次。</p>\n<p>这与他们9月份的预测相比有变化。当时,决策者在2022年或2023年首次加息的预测上平分秋色。</p>\n<p>“这将是点阵图历史上最大的鹰派转变,”Macropolicy Perspectives高级经济学家Laura Rosner-Warburton表示。美联储自2012年开始发布利率预测的点阵图。</p>\n<p><img src=\"https://n.sinaimg.cn/tech/transform/395/w512h683/20211213/2dd2-a526974a89f50d8229b23ab688835d45.png\" tg-width=\"512\" tg-height=\"683\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p><b>特斯拉CEO埃隆·马斯克当选时代杂志2021年度风云人物</b></p>\n<p>据报道,特斯拉CEO埃隆·马斯克(Elon Musk)今日被美国《时代》杂志评为“2021年度风云人物”。</p>\n<p>《时代》杂志称,作为世界上最富有的人,他没有房子,最近一直在抛售财产。他将卫星送入轨道,并利用<a href=\"https://laohu8.com/S/000591\">太阳能</a>服务千家万户。他驾驶着一辆自己制造的汽车,不需要汽油,也几乎不需要司机。他的手指一挥,股市就会暴涨或暴跌。他的每一句话都被一大群粉丝挂在嘴边。当他把业务推向全球时,还梦想着移民火星。</p>\n<p><img src=\"https://static.tigerbbs.com/4133304c52fa226b469ba60f980192f1\" tg-width=\"550\" tg-height=\"310\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p><b>牛津大学:omicron毒株能削弱两针辉瑞或阿斯利康疫苗的保护力</b></p>\n<p>研究人员发现,正如人们所担忧的一样,omicron变异株削弱了辉瑞和阿斯利康两剂新冠疫苗所能提供的保护力,增加了接种者感染风险。</p>\n<p>牛津大学研究人员周一在一份报告中表示,在对接种辉瑞或阿斯利康疫苗的人采集的血液样本中,经检测新毒株omicron令中和抗体大幅减少,尤其是和德尔塔毒株相比,降幅很明显。</p>\n<p>阿斯利康疫苗的创造者之一Teresa Lambe表示,在接下来的几周,omicron的影响应该会得到更好的记录,以明确是否需要接种新疫苗。</p>\n<p>“我们希望当前的疫苗能够预防严重疾病和住院治疗”,Lambe表示。 “我们和其他疫苗生产商的立场是,如果需要一种针对新毒株的疫苗,我们可以快速推进。”</p>\n<p><img src=\"https://static.tigerbbs.com/7eb99a948e8b987f3e2c4401c8f7e901\" tg-width=\"550\" tg-height=\"309\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p><b>七国集团财长承诺解决供应链问题并避免未来重演</b></p>\n<p>七国集团财长承诺加强合作,以解决造成商品短缺和通胀飙升的全球供应链问题。</p>\n<p>由于运输问题导致供应中断,零部件制成品短缺以及疫情造成能源价格上涨,全球消费者价格都在飙升。美国通胀率已触及1982年以来的最高水平,欧元区通胀率达到了创纪录的4.9%。</p>\n<p>在七国集团财长和央行行长会议的最后公报中,轮值主席国英国的财政大臣Rishi Sunak称,该组织将着眼于预测并避免未来的供应紧张。</p>\n<p>英国财政部表示,七国集团财长和央行行长们“就如何提高供应链韧性以及如何更准确地预测未来可能发生的干扰交换了看法”。</p>\n<p><img src=\"https://static.tigerbbs.com/5d92536ec41518383402813fee58b8bc\" tg-width=\"550\" tg-height=\"407\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p><b>小摩预计美失业率明年将降至3%左右 奥密克戎是就业市场主要风险</b></p>\n<p><a href=\"https://laohu8.com/S/JPM\">摩根大通</a>首席美国经济学家Michael Feroli认为,2022年美国失业率将下降。</p>\n<p>“我认为到2022年底可以看到失业率在3%左右,”Feroli称。“过去五个月的失业率下降幅度令人深刻印象。我们预计下降速度会放缓,但很快就会降至4%以下。”</p>\n<p>在Feroli看来,随着雇主寻找人才以推动企业从疫情中复苏,就业市场可能会以良好的势头进入2022年。</p>\n<p>Feroli还预计,明年美国GDP将增长3%。他认为,美联储将在9月开始加息以抵消通胀,而通胀在一定程度上是由于劳动力市场状况吃紧。</p>\n<p>此外,就业市场的一个主要风险仍然是奥密克戎变体及其是否会减缓企业的招聘计划。</p>","source":"sina","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>外媒头条:美联储可能上演历史罕见鹰派转变</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n外媒头条:美联储可能上演历史罕见鹰派转变\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-14 05:40 北京时间 <a href=https://finance.sina.com.cn/stock/usstock/c/2021-12-14/doc-ikyakumx3975846.shtml><strong>市场资讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>全球财经媒体昨夜今晨共同关注的头条新闻主要有:\n\n1、纽约联储调查显示:消费者对未来一年的通胀预期升至6%的新高\n\n\n2、加速减码+预告加息 美联储可能上演历史罕见的鹰派转变\n\n\n3、特斯拉CEO埃隆·马斯克当选时代杂志2021年度风云人物\n\n\n4、牛津大学:omicron毒株能削弱两针辉瑞或阿斯利康疫苗的保护力\n\n\n5、七国集团财长承诺解决供应链问题并避免未来重演\n\n\n6、小摩预计美失业率明年将...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2021-12-14/doc-ikyakumx3975846.shtml\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/02a85629f2a809e4eabd8677140a5f70","relate_stocks":{"161125":"标普500","513500":"标普500ETF","QQQ":"纳指100ETF","DOG":"道指反向ETF",".DJI":"道琼斯","SDS":"两倍做空标普500ETF",".IXIC":"NASDAQ Composite","UDOW":"道指三倍做多ETF-ProShares","BK4504":"桥水持仓","OEX":"标普100",".SPX":"S&P 500 Index","SDOW":"道指三倍做空ETF-ProShares","QID":"纳指两倍做空ETF","SSO":"两倍做多标普500ETF","SPXU":"三倍做空标普500ETF","DJX":"1/100道琼斯","OEF":"标普100指数ETF-iShares","SQQQ":"纳指三倍做空ETF","BK4534":"瑞士信贷持仓","DXD":"道指两倍做空ETF","QLD":"纳指两倍做多ETF","PSQ":"纳指反向ETF","SPY":"标普500ETF","IVV":"标普500指数ETF","SH":"标普500反向ETF","DDM":"道指两倍做多ETF","BK4559":"巴菲特持仓","BK4550":"红杉资本持仓","UPRO":"三倍做多标普500ETF","TQQQ":"纳指三倍做多ETF"},"source_url":"https://finance.sina.com.cn/stock/usstock/c/2021-12-14/doc-ikyakumx3975846.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","article_id":"2191098415","content_text":"全球财经媒体昨夜今晨共同关注的头条新闻主要有:\n\n1、纽约联储调查显示:消费者对未来一年的通胀预期升至6%的新高\n\n\n2、加速减码+预告加息 美联储可能上演历史罕见的鹰派转变\n\n\n3、特斯拉CEO埃隆·马斯克当选时代杂志2021年度风云人物\n\n\n4、牛津大学:omicron毒株能削弱两针辉瑞或阿斯利康疫苗的保护力\n\n\n5、七国集团财长承诺解决供应链问题并避免未来重演\n\n\n6、小摩预计美失业率明年将降至3%左右 奥密克戎是就业市场主要风险\n\n\n纽约联储调查显示:消费者对未来一年的通胀预期升至6%的新高\n纽约联邦储备银行最新消费者调查显示,美国消费者对未来一年的通胀预期升至6%的新高。\n调查还显示,三年通胀预期自6月以来首次下降,达到4%,主要是受到无大学学历受访者的预期推动。然而,无论是短期还是长期,通胀的不确定性水平都在上升,并且都达到了历史新高。\n这一结果凸显出近期令美联储和大多数经济学家感到意外的通胀飙升的不可预测性。美联储可能在即将召开的政策会议上宣布加快减码债券收购的步伐。\n调查还显示,消费者对经济的乐观程度下降。\n调查显示,美国未来一年失业率上升的平均概率提高了0.6个百分点。11月受访者对与一年前相比家庭当前财务状况的看法有所恶化,更多受访者称财务状况变差。\n\n加速减码+预告加息 美联储可能上演历史罕见的鹰派转变\n经济学家预计,美联储官员本周将加快收缩购债步伐,并发出2022年加息的信号,在1980年代以来最强通胀面前上演历史性的政策转变。\n超过一半的受访者预计,美联储周三结束两天政策会议后发布的季度预测将显示,18位官员的中值预测是明年加息两次。\n这与他们9月份的预测相比有变化。当时,决策者在2022年或2023年首次加息的预测上平分秋色。\n“这将是点阵图历史上最大的鹰派转变,”Macropolicy Perspectives高级经济学家Laura Rosner-Warburton表示。美联储自2012年开始发布利率预测的点阵图。\n\n特斯拉CEO埃隆·马斯克当选时代杂志2021年度风云人物\n据报道,特斯拉CEO埃隆·马斯克(Elon Musk)今日被美国《时代》杂志评为“2021年度风云人物”。\n《时代》杂志称,作为世界上最富有的人,他没有房子,最近一直在抛售财产。他将卫星送入轨道,并利用太阳能服务千家万户。他驾驶着一辆自己制造的汽车,不需要汽油,也几乎不需要司机。他的手指一挥,股市就会暴涨或暴跌。他的每一句话都被一大群粉丝挂在嘴边。当他把业务推向全球时,还梦想着移民火星。\n\n牛津大学:omicron毒株能削弱两针辉瑞或阿斯利康疫苗的保护力\n研究人员发现,正如人们所担忧的一样,omicron变异株削弱了辉瑞和阿斯利康两剂新冠疫苗所能提供的保护力,增加了接种者感染风险。\n牛津大学研究人员周一在一份报告中表示,在对接种辉瑞或阿斯利康疫苗的人采集的血液样本中,经检测新毒株omicron令中和抗体大幅减少,尤其是和德尔塔毒株相比,降幅很明显。\n阿斯利康疫苗的创造者之一Teresa Lambe表示,在接下来的几周,omicron的影响应该会得到更好的记录,以明确是否需要接种新疫苗。\n“我们希望当前的疫苗能够预防严重疾病和住院治疗”,Lambe表示。 “我们和其他疫苗生产商的立场是,如果需要一种针对新毒株的疫苗,我们可以快速推进。”\n\n七国集团财长承诺解决供应链问题并避免未来重演\n七国集团财长承诺加强合作,以解决造成商品短缺和通胀飙升的全球供应链问题。\n由于运输问题导致供应中断,零部件制成品短缺以及疫情造成能源价格上涨,全球消费者价格都在飙升。美国通胀率已触及1982年以来的最高水平,欧元区通胀率达到了创纪录的4.9%。\n在七国集团财长和央行行长会议的最后公报中,轮值主席国英国的财政大臣Rishi Sunak称,该组织将着眼于预测并避免未来的供应紧张。\n英国财政部表示,七国集团财长和央行行长们“就如何提高供应链韧性以及如何更准确地预测未来可能发生的干扰交换了看法”。\n\n小摩预计美失业率明年将降至3%左右 奥密克戎是就业市场主要风险\n摩根大通首席美国经济学家Michael Feroli认为,2022年美国失业率将下降。\n“我认为到2022年底可以看到失业率在3%左右,”Feroli称。“过去五个月的失业率下降幅度令人深刻印象。我们预计下降速度会放缓,但很快就会降至4%以下。”\n在Feroli看来,随着雇主寻找人才以推动企业从疫情中复苏,就业市场可能会以良好的势头进入2022年。\nFeroli还预计,明年美国GDP将增长3%。他认为,美联储将在9月开始加息以抵消通胀,而通胀在一定程度上是由于劳动力市场状况吃紧。\n此外,就业市场的一个主要风险仍然是奥密克戎变体及其是否会减缓企业的招聘计划。","news_type":1},"isVote":1,"tweetType":1,"viewCount":838,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604800763,"gmtCreate":1639364649863,"gmtModify":1639364924275,"author":{"id":"3573948076022422","authorId":"3573948076022422","name":"Annie12345","avatar":"https://static.tigerbbs.com/b7529e308acffa5522a9e9690d9dcae6","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573948076022422","authorIdStr":"3573948076022422"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604800763","repostId":"605462650","repostType":1,"repost":{"id":605462650,"gmtCreate":1639222201797,"gmtModify":1639233253732,"author":{"id":"3569316529855154","authorId":"3569316529855154","name":"Deonc","avatar":"https://static.tigerbbs.com/d9aa45dd2eb58357f6477dcfb99d1415","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569316529855154","authorIdStr":"3569316529855154"},"themes":[],"title":"Sea Limited drops to end week","htmlText":"Sea Limited drops to end week as Hedgeye calls it a top short idea Back view of young gamer playing video games on computerSea Limited (NYSE:SE) ended the week on a low note, dropping 6.6% today after being named as a best idea short at Hedgeye.Shares had pulled back some 30% from their all-time highs already, analyst Felix Wang notes, but says the valuation is still \"lofty\" - and has room for another 35% downside.The company is facing more competitive pressure, he says, and some of the routes forward aren't as solid as expected. Sea is looking to Brazil to support international growth, but Wang says the gaming opportunity in Brazil is \"hyped\" and e-commerce there is shaky as well.As for its flagship game Garena Free Fire, it's a \"one-hit wonder whose performance has peaked,\" with engageme","listText":"Sea Limited drops to end week as Hedgeye calls it a top short idea Back view of young gamer playing video games on computerSea Limited (NYSE:SE) ended the week on a low note, dropping 6.6% today after being named as a best idea short at Hedgeye.Shares had pulled back some 30% from their all-time highs already, analyst Felix Wang notes, but says the valuation is still \"lofty\" - and has room for another 35% downside.The company is facing more competitive pressure, he says, and some of the routes forward aren't as solid as expected. Sea is looking to Brazil to support international growth, but Wang says the gaming opportunity in Brazil is \"hyped\" and e-commerce there is shaky as well.As for its flagship game Garena Free Fire, it's a \"one-hit wonder whose performance has peaked,\" with engageme","text":"Sea Limited drops to end week as Hedgeye calls it a top short idea Back view of young gamer playing video games on computerSea Limited (NYSE:SE) ended the week on a low note, dropping 6.6% today after being named as a best idea short at Hedgeye.Shares had pulled back some 30% from their all-time highs already, analyst Felix Wang notes, but says the valuation is still \"lofty\" - and has room for another 35% downside.The company is facing more competitive pressure, he says, and some of the routes forward aren't as solid as expected. Sea is looking to Brazil to support international growth, but Wang says the gaming opportunity in Brazil is \"hyped\" and e-commerce there is shaky as well.As for its flagship game Garena Free Fire, it's a \"one-hit wonder whose performance has peaked,\" with engageme","images":[],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605462650","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1121,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604800494,"gmtCreate":1639364635421,"gmtModify":1639364923690,"author":{"id":"3573948076022422","authorId":"3573948076022422","name":"Annie12345","avatar":"https://static.tigerbbs.com/b7529e308acffa5522a9e9690d9dcae6","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573948076022422","authorIdStr":"3573948076022422"},"themes":[],"htmlText":"O","listText":"O","text":"O","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604800494","repostId":"605477626","repostType":1,"repost":{"id":605477626,"gmtCreate":1639236121452,"gmtModify":1639399159414,"author":{"id":"3548388348794551","authorId":"3548388348794551","name":"问就是加仓up","avatar":"https://static.tigerbbs.com/4e98ddf789d46c5627f944fc581c0fe9","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3548388348794551","authorIdStr":"3548388348794551"},"themes":[],"title":"2021年复盘:大赚到接近清零,回本绝对是最浪漫的事","htmlText":"又到了年底复盘的时候,今年炒股体验真的极度复杂,年初觉得自己是股神, 年中觉得自己是韭菜,年底两个月又觉得自己能行了。这一年心路历程不是一篇帖子能够描述的,但还是希望通过年度复盘给大家还原一些比较有意义的观点。 这是去年的复盘链接 <a href=\"https://laohu8.com/TW/331834662\" target=\"_blank\">2020总结:美股10倍,港股2倍,A股:赚钱是甚么</a> 今年的复盘主要分5个部分,收益复盘,操作复盘,一些感悟,交易手法,未来展望。文章有点长,可以直接跳转看自己感兴趣的部分。 1,收益:勉强保本 今年账户保本小赚,年中的时候一度大亏,在10月份开始飞速回本了,之后一路操作很多,但是也没啥大的收益。至于说收益图基本上也没法看,因为今年出入金频率太高,曲线都是-99%,因为中途出现过账户暴跌。但是由于控制了账户资金,没有受伤很严重。 这个图是12月10日截图,截止到今天一共交易了470w美金,交易频率比较高。累计交易了205只,其中盈利的只有43只,基本上就是赚钱的拿得住,赔钱的跑得快,当然也因此卖飞了不少股票。截止到今天一共挣了1600刀,收益率多少,我也不知道,根本算不出来。 另外今年开了N多的账户打新(几十个),这也是资金进出频繁的一个原因,不过这些账户都是亏钱出局,4月份之后基本上不打新了,打新是今年的一个重要亏损点。如果把所有账户加起来,今年基本上没赚钱,因为还有一个大账户也小有盈利,差不多可以把各种打野的亏损平衡掉。 2,操作复盘 每个月都有一些神之操作,每个月都有不一样的槽点。文中的时间节点可能记得不是那么清晰,相关操作之前发帖子也有提过,主要说一些印象比较深刻的。 1月份 中概股暴涨完整的吃到了,而且这也是账户高频交易的开始,当时买老虎股票,从6美金涨到了38美金(环球账户被清空了,没法晒)","listText":"又到了年底复盘的时候,今年炒股体验真的极度复杂,年初觉得自己是股神, 年中觉得自己是韭菜,年底两个月又觉得自己能行了。这一年心路历程不是一篇帖子能够描述的,但还是希望通过年度复盘给大家还原一些比较有意义的观点。 这是去年的复盘链接 <a href=\"https://laohu8.com/TW/331834662\" target=\"_blank\">2020总结:美股10倍,港股2倍,A股:赚钱是甚么</a> 今年的复盘主要分5个部分,收益复盘,操作复盘,一些感悟,交易手法,未来展望。文章有点长,可以直接跳转看自己感兴趣的部分。 1,收益:勉强保本 今年账户保本小赚,年中的时候一度大亏,在10月份开始飞速回本了,之后一路操作很多,但是也没啥大的收益。至于说收益图基本上也没法看,因为今年出入金频率太高,曲线都是-99%,因为中途出现过账户暴跌。但是由于控制了账户资金,没有受伤很严重。 这个图是12月10日截图,截止到今天一共交易了470w美金,交易频率比较高。累计交易了205只,其中盈利的只有43只,基本上就是赚钱的拿得住,赔钱的跑得快,当然也因此卖飞了不少股票。截止到今天一共挣了1600刀,收益率多少,我也不知道,根本算不出来。 另外今年开了N多的账户打新(几十个),这也是资金进出频繁的一个原因,不过这些账户都是亏钱出局,4月份之后基本上不打新了,打新是今年的一个重要亏损点。如果把所有账户加起来,今年基本上没赚钱,因为还有一个大账户也小有盈利,差不多可以把各种打野的亏损平衡掉。 2,操作复盘 每个月都有一些神之操作,每个月都有不一样的槽点。文中的时间节点可能记得不是那么清晰,相关操作之前发帖子也有提过,主要说一些印象比较深刻的。 1月份 中概股暴涨完整的吃到了,而且这也是账户高频交易的开始,当时买老虎股票,从6美金涨到了38美金(环球账户被清空了,没法晒)","text":"又到了年底复盘的时候,今年炒股体验真的极度复杂,年初觉得自己是股神, 年中觉得自己是韭菜,年底两个月又觉得自己能行了。这一年心路历程不是一篇帖子能够描述的,但还是希望通过年度复盘给大家还原一些比较有意义的观点。 这是去年的复盘链接 2020总结:美股10倍,港股2倍,A股:赚钱是甚么 今年的复盘主要分5个部分,收益复盘,操作复盘,一些感悟,交易手法,未来展望。文章有点长,可以直接跳转看自己感兴趣的部分。 1,收益:勉强保本 今年账户保本小赚,年中的时候一度大亏,在10月份开始飞速回本了,之后一路操作很多,但是也没啥大的收益。至于说收益图基本上也没法看,因为今年出入金频率太高,曲线都是-99%,因为中途出现过账户暴跌。但是由于控制了账户资金,没有受伤很严重。 这个图是12月10日截图,截止到今天一共交易了470w美金,交易频率比较高。累计交易了205只,其中盈利的只有43只,基本上就是赚钱的拿得住,赔钱的跑得快,当然也因此卖飞了不少股票。截止到今天一共挣了1600刀,收益率多少,我也不知道,根本算不出来。 另外今年开了N多的账户打新(几十个),这也是资金进出频繁的一个原因,不过这些账户都是亏钱出局,4月份之后基本上不打新了,打新是今年的一个重要亏损点。如果把所有账户加起来,今年基本上没赚钱,因为还有一个大账户也小有盈利,差不多可以把各种打野的亏损平衡掉。 2,操作复盘 每个月都有一些神之操作,每个月都有不一样的槽点。文中的时间节点可能记得不是那么清晰,相关操作之前发帖子也有提过,主要说一些印象比较深刻的。 1月份 中概股暴涨完整的吃到了,而且这也是账户高频交易的开始,当时买老虎股票,从6美金涨到了38美金(环球账户被清空了,没法晒)","images":[{"img":"https://static.tigerbbs.com/fad4be5c0b8c595847d68aaeb0d403c7","width":"-1","height":"-1"},{"img":"https://static.tigerbbs.com/b997c7eb8dab40ed1a413c3502e16b53","width":"-1","height":"-1"},{"img":"https://static.tigerbbs.com/ccf5b3b2ff1b8703b1e8a4f1dfac346c","width":"-1","height":"-1"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605477626","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":16,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":780,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609468359,"gmtCreate":1638318245027,"gmtModify":1638318245250,"author":{"id":"3573948076022422","authorId":"3573948076022422","name":"Annie12345","avatar":"https://static.tigerbbs.com/b7529e308acffa5522a9e9690d9dcae6","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573948076022422","authorIdStr":"3573948076022422"},"themes":[],"htmlText":"Hopefully today turn green ","listText":"Hopefully today turn green ","text":"Hopefully today turn green","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609468359","repostId":"1129769141","repostType":4,"repost":{"id":"1129769141","pubTimestamp":1638317199,"share":"https://www.laohu8.com/m/news/1129769141?lang=&edition=full","pubTime":"2021-12-01 08:06","market":"us","language":"en","title":"Oversold Singapore Bourse Called Lower Again","url":"https://stock-news.laohu8.com/highlight/detail?id=1129769141","media":"RTTNews","summary":"The Singapore stock market has finished lower in six straight trading days, sinking almost 200 point","content":"<p>The Singapore stock market has finished lower in six straight trading days, sinking almost 200 points or 6.4 percent along the way. The Straits Times Index now sits just above the 3,040-point plateau and it's got another weak lead for Wednesday's trade.</p>\n<p>The global forecast for the Asian markets suggests consolidation on continued COVID-19 worries and concerns over the outlook for interest rates. The European and U.S. markets were down and the Asian markets figure to open in similar fashion.</p>\n<p>The STI finished sharply lower on Tuesday with damage across the board, especially from the financials and industrials.</p>\n<p>For the day, the index plunged 79.29 points or 2.54 percent to finish at the daily low of 3,041.29 after peaking at 3,129.54. Volume was 3.22 billion shares worth 3.89 billion Singapore dollars. There were 338 decliners and 172 gainers.</p>\n<p>Among the actives, Ascendas REIT slumped 2.34 percent, while CapitaLand Integrated Commercial Trust and Jardine Cycle both fell 1.40 percent, City Developments added 0.29 percent, Comfort DelGro plummeted 4.20 percent, Dairy Farm International and Thai Beverage both weakened 2.19 percent, DBS Group declined 2.99 percent, Genting Singapore skidded 2.53 percent, Keppel Corp sank 2.11 percent, Mapletree Commercial Trust stumbled 2.39 percent, Mapletree Logistics Trust lost 1.87 percent, Oversea-Chinese Banking Corporation surrendered 3.17 percent, SATS retreated 2.56 percent, SembCorp Industries plunged 4.08 percent, Singapore Airlines slid 0.81 percent, Singapore Exchange tumbled 3.25 percent, Singapore Press Holdings eased 0.43 percent, Singapore Technologies Engineering was down 0.78 percent, SingTel dropped 2.07 percent, United Overseas Bank tanked 4.00 percent, Wilmar International shed 1.91 percent and Yangzijiang Shipbuilding was unchanged.</p>\n<p>The lead from Wall Street is broadly negative as the major averages opened lower on Tuesday and remained largely under water throughout the trading day.</p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oversold Singapore Bourse Called Lower Again</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOversold Singapore Bourse Called Lower Again\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-01 08:06 GMT+8 <a href=https://www.rttnews.com/3245823/oversold-singapore-bourse-called-lower-again.aspx?type=acom><strong>RTTNews</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Singapore stock market has finished lower in six straight trading days, sinking almost 200 points or 6.4 percent along the way. The Straits Times Index now sits just above the 3,040-point plateau ...</p>\n\n<a href=\"https://www.rttnews.com/3245823/oversold-singapore-bourse-called-lower-again.aspx?type=acom\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"O39.SI":"华侨银行","C6L.SI":"新加坡航空公司","STI.SI":"富时新加坡海峡指数","D05.SI":"星展集团控股","BVA.SI":"顶级手套有限公司"},"source_url":"https://www.rttnews.com/3245823/oversold-singapore-bourse-called-lower-again.aspx?type=acom","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129769141","content_text":"The Singapore stock market has finished lower in six straight trading days, sinking almost 200 points or 6.4 percent along the way. The Straits Times Index now sits just above the 3,040-point plateau and it's got another weak lead for Wednesday's trade.\nThe global forecast for the Asian markets suggests consolidation on continued COVID-19 worries and concerns over the outlook for interest rates. The European and U.S. markets were down and the Asian markets figure to open in similar fashion.\nThe STI finished sharply lower on Tuesday with damage across the board, especially from the financials and industrials.\nFor the day, the index plunged 79.29 points or 2.54 percent to finish at the daily low of 3,041.29 after peaking at 3,129.54. Volume was 3.22 billion shares worth 3.89 billion Singapore dollars. There were 338 decliners and 172 gainers.\nAmong the actives, Ascendas REIT slumped 2.34 percent, while CapitaLand Integrated Commercial Trust and Jardine Cycle both fell 1.40 percent, City Developments added 0.29 percent, Comfort DelGro plummeted 4.20 percent, Dairy Farm International and Thai Beverage both weakened 2.19 percent, DBS Group declined 2.99 percent, Genting Singapore skidded 2.53 percent, Keppel Corp sank 2.11 percent, Mapletree Commercial Trust stumbled 2.39 percent, Mapletree Logistics Trust lost 1.87 percent, Oversea-Chinese Banking Corporation surrendered 3.17 percent, SATS retreated 2.56 percent, SembCorp Industries plunged 4.08 percent, Singapore Airlines slid 0.81 percent, Singapore Exchange tumbled 3.25 percent, Singapore Press Holdings eased 0.43 percent, Singapore Technologies Engineering was down 0.78 percent, SingTel dropped 2.07 percent, United Overseas Bank tanked 4.00 percent, Wilmar International shed 1.91 percent and Yangzijiang Shipbuilding was unchanged.\nThe lead from Wall Street is broadly negative as the major averages opened lower on Tuesday and remained largely under water throughout the trading day.","news_type":1},"isVote":1,"tweetType":1,"viewCount":699,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600079187,"gmtCreate":1638023420408,"gmtModify":1638023420654,"author":{"id":"3573948076022422","authorId":"3573948076022422","name":"Annie12345","avatar":"https://static.tigerbbs.com/b7529e308acffa5522a9e9690d9dcae6","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573948076022422","authorIdStr":"3573948076022422"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600079187","repostId":"875206593","repostType":1,"repost":{"id":875206593,"gmtCreate":1637653011508,"gmtModify":1637923972899,"author":{"id":"3585780691540522","authorId":"3585780691540522","name":"FundMall","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585780691540522","authorIdStr":"3585780691540522"},"themes":[],"title":"Fund College: When should you take profit?","htmlText":"One pertinent question investors commonly ask themselves is: ‘when should I take profits?’. This is no doubt a tough question to answer since we as investors are always seeking higher returns from our investments. In today’s article, we will break down our thoughts on this topic for our platform’s investors. To begin with, there is nothing wrong with chasing more returns despite having your investments in the green. However, we think that it is a good practice to review your portfolio at the end of the year or even the start of the year, even if you have a time horizon of ten years or more, given that sometimes a certain investment may become a huge part in your portfolio, especially if it has rallied aggressively. Take for example you have invested in the technology sector during the Covi","listText":"One pertinent question investors commonly ask themselves is: ‘when should I take profits?’. This is no doubt a tough question to answer since we as investors are always seeking higher returns from our investments. In today’s article, we will break down our thoughts on this topic for our platform’s investors. To begin with, there is nothing wrong with chasing more returns despite having your investments in the green. However, we think that it is a good practice to review your portfolio at the end of the year or even the start of the year, even if you have a time horizon of ten years or more, given that sometimes a certain investment may become a huge part in your portfolio, especially if it has rallied aggressively. Take for example you have invested in the technology sector during the Covi","text":"One pertinent question investors commonly ask themselves is: ‘when should I take profits?’. This is no doubt a tough question to answer since we as investors are always seeking higher returns from our investments. In today’s article, we will break down our thoughts on this topic for our platform’s investors. To begin with, there is nothing wrong with chasing more returns despite having your investments in the green. However, we think that it is a good practice to review your portfolio at the end of the year or even the start of the year, even if you have a time horizon of ten years or more, given that sometimes a certain investment may become a huge part in your portfolio, especially if it has rallied aggressively. Take for example you have invested in the technology sector during the Covi","images":[],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875206593","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":788,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600070485,"gmtCreate":1638023358779,"gmtModify":1638023358976,"author":{"id":"3573948076022422","authorId":"3573948076022422","name":"Annie12345","avatar":"https://static.tigerbbs.com/b7529e308acffa5522a9e9690d9dcae6","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573948076022422","authorIdStr":"3573948076022422"},"themes":[],"htmlText":"O","listText":"O","text":"O","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/600070485","repostId":"2186344334","repostType":4,"repost":{"id":"2186344334","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1637967996,"share":"https://www.laohu8.com/m/news/2186344334?lang=&edition=full","pubTime":"2021-11-27 07:06","market":"hk","language":"en","title":"Dow plunges 905 points in Black Friday selloff, books worst day in over a year as WHO declares new COVID 'variant of concern'","url":"https://stock-news.laohu8.com/highlight/detail?id=2186344334","media":"Dow Jones","summary":"Dow notches worst day for blue chips since Oct. 28, 2020, FactSet data show\nU.S. stock benchmarks su","content":"<p>Dow notches worst day for blue chips since Oct. 28, 2020, FactSet data show</p>\n<p>U.S. stock benchmarks suffered withering losses on Friday as stock and commodity markets plunged, after scientists detected a new COVID variant in South Africa that could be to blame for a recent sharp surge in cases, especially in Europe.</p>\n<p>U.S. markets were closed for Thanksgiving on Thursday and ended at 1 p.m. Eastern Time on Friday, three hours earlier than usual, and bond market trading ends at 2 p.m., an hour earlier than is typical.</p>\n<p>How are stock-index futures trading?</p>\n<p>On Wednesday, the Dow industrials fell 9.42 points to finish nearly flat at 35,804.38. The S&P 500 slipped 0.2% to close at 4,701.46, just 0.1% below its Nov. 18 record close of 4,704.54, according to Dow Jones Market Data. The Nasdaq Composite Index rose 0.4% to 15,84.23.</p>\n<p>What's driving the market?</p>\n<p>It was an ugly day for stock investors during a thinly traded Black Friday session, which was susceptible to big swings on alarming news from public health officials who were assessing a new variant of the coronavirus that causes COVID-19.</p>\n<p>Late in the session, the World Health Organization's technical advisory group assigned the B. 1.1.529 variant of the virus the Greek letter omicron and declared it a \"variant of concern,\" as it did with the delta variant.</p>\n<p>Fear of a new variant overshadowed the usual focus on U.S. Black Friday shopping day, which puts the focus on retailers as consumers shop for bargains.</p>\n<p>Particularly notable about the variant is the \"large number of mutations, some of which are concerning,\" the WHO group said in a statement. The mutations could make omicron more resistant to the current batch of vaccines.</p>\n<p>The discovery of the new COVID strain was announced on Friday by South Africa's health minister Joe Phaahla. He said scientists were concerned because of its high number of mutations and the dramatic surge in infections the country had seen over the past four or five days.</p>\n<p>\"The pandemic and COVID variants remain <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the biggest risks to markets, and are likely to continue to inject volatility over the next year(s),\" wrote Keith Lerner, co-chief investment officer and chief market strategist at Truist Advisory Services, in a Friday note. \"It's hard to say at this point how lasting or impactful this latest variant will be for markets,\" the analyst wrote.</p>\n<p>The omicron strain has been detected in Botswana and in Hong Kong in travelers who had visited South Africa.</p>\n<p>\"The one bull in the China shop that could truly derail the global recovery has always been a new strain of Covid-19 that swept the world and caused the reimposition of mass social retractions,\" said Jeffrey Halley, senior market analyst, at OANDA, in a note. \"All we know so far is the B. 1.1.529 is heavily mutated but markets are taking no chances.\"</p>\n<p>\"Just when you thought Covid was being controlled in a holiday shortened week,\" said Sam Stovall, chief investment strategist at CFRA Research, in emailed comments.</p>\n<p>Trading around the Thanksgiving holiday is often associated with lower trading volumes as traders typically wait until Monday to return to work. There was no U.S. economic data on the calendar for Friday.</p>\n<p>After new cases stabilized at 200 a day, South Africa reported more than 1,200 on Wednesday and 2,465 on Thursday.</p>\n<p>The U.K. government is banning flights from South Africa along with five other African nations, effective Friday.</p>\n<p>\"Predictably, energy, travel related and financials are the leading decliners and treasuries are rallying,\" wrote Jay Hatfield, CEO and portfolio manager at Infrastructure Capital Management, in emailed comments on Friday.</p>\n<p>\"It makes sense to have a market significant correction given the high level of uncertainty,\" the money manager wrote.</p>\n<p>\"At this stage very little is known,\" Deutsche Bank strategists, led by Jim Reid, told clients in a note. \"Mutations are often less severe so we shouldn't jump to conclusions but there is clearly a lot of concern about this one. Also South Africa is one of the world leaders in sequencing so we are more likely to see this sort of news originate from there than many countries. Suffice to say at this stage no one in markets will have any idea which way this will go.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow plunges 905 points in Black Friday selloff, books worst day in over a year as WHO declares new COVID 'variant of concern'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow plunges 905 points in Black Friday selloff, books worst day in over a year as WHO declares new COVID 'variant of concern'\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-11-27 07:06</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dow notches worst day for blue chips since Oct. 28, 2020, FactSet data show</p>\n<p>U.S. stock benchmarks suffered withering losses on Friday as stock and commodity markets plunged, after scientists detected a new COVID variant in South Africa that could be to blame for a recent sharp surge in cases, especially in Europe.</p>\n<p>U.S. markets were closed for Thanksgiving on Thursday and ended at 1 p.m. Eastern Time on Friday, three hours earlier than usual, and bond market trading ends at 2 p.m., an hour earlier than is typical.</p>\n<p>How are stock-index futures trading?</p>\n<p>On Wednesday, the Dow industrials fell 9.42 points to finish nearly flat at 35,804.38. The S&P 500 slipped 0.2% to close at 4,701.46, just 0.1% below its Nov. 18 record close of 4,704.54, according to Dow Jones Market Data. The Nasdaq Composite Index rose 0.4% to 15,84.23.</p>\n<p>What's driving the market?</p>\n<p>It was an ugly day for stock investors during a thinly traded Black Friday session, which was susceptible to big swings on alarming news from public health officials who were assessing a new variant of the coronavirus that causes COVID-19.</p>\n<p>Late in the session, the World Health Organization's technical advisory group assigned the B. 1.1.529 variant of the virus the Greek letter omicron and declared it a \"variant of concern,\" as it did with the delta variant.</p>\n<p>Fear of a new variant overshadowed the usual focus on U.S. Black Friday shopping day, which puts the focus on retailers as consumers shop for bargains.</p>\n<p>Particularly notable about the variant is the \"large number of mutations, some of which are concerning,\" the WHO group said in a statement. The mutations could make omicron more resistant to the current batch of vaccines.</p>\n<p>The discovery of the new COVID strain was announced on Friday by South Africa's health minister Joe Phaahla. He said scientists were concerned because of its high number of mutations and the dramatic surge in infections the country had seen over the past four or five days.</p>\n<p>\"The pandemic and COVID variants remain <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the biggest risks to markets, and are likely to continue to inject volatility over the next year(s),\" wrote Keith Lerner, co-chief investment officer and chief market strategist at Truist Advisory Services, in a Friday note. \"It's hard to say at this point how lasting or impactful this latest variant will be for markets,\" the analyst wrote.</p>\n<p>The omicron strain has been detected in Botswana and in Hong Kong in travelers who had visited South Africa.</p>\n<p>\"The one bull in the China shop that could truly derail the global recovery has always been a new strain of Covid-19 that swept the world and caused the reimposition of mass social retractions,\" said Jeffrey Halley, senior market analyst, at OANDA, in a note. \"All we know so far is the B. 1.1.529 is heavily mutated but markets are taking no chances.\"</p>\n<p>\"Just when you thought Covid was being controlled in a holiday shortened week,\" said Sam Stovall, chief investment strategist at CFRA Research, in emailed comments.</p>\n<p>Trading around the Thanksgiving holiday is often associated with lower trading volumes as traders typically wait until Monday to return to work. There was no U.S. economic data on the calendar for Friday.</p>\n<p>After new cases stabilized at 200 a day, South Africa reported more than 1,200 on Wednesday and 2,465 on Thursday.</p>\n<p>The U.K. government is banning flights from South Africa along with five other African nations, effective Friday.</p>\n<p>\"Predictably, energy, travel related and financials are the leading decliners and treasuries are rallying,\" wrote Jay Hatfield, CEO and portfolio manager at Infrastructure Capital Management, in emailed comments on Friday.</p>\n<p>\"It makes sense to have a market significant correction given the high level of uncertainty,\" the money manager wrote.</p>\n<p>\"At this stage very little is known,\" Deutsche Bank strategists, led by Jim Reid, told clients in a note. \"Mutations are often less severe so we shouldn't jump to conclusions but there is clearly a lot of concern about this one. Also South Africa is one of the world leaders in sequencing so we are more likely to see this sort of news originate from there than many countries. Suffice to say at this stage no one in markets will have any idea which way this will go.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4554":"元宇宙及AR概念","BK4566":"资本集团","BK4525":"远程办公概念","BK4532":"文艺复兴科技持仓","BK4548":"巴美列捷福持仓","BK4528":"SaaS概念","BK4551":"寇图资本持仓","ZM":"Zoom","BK4535":"淡马锡持仓","PTON":"Peloton Interactive, Inc.","BK4505":"高瓴资本持仓","BK4190":"消闲用品","BK4023":"应用软件"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2186344334","content_text":"Dow notches worst day for blue chips since Oct. 28, 2020, FactSet data show\nU.S. stock benchmarks suffered withering losses on Friday as stock and commodity markets plunged, after scientists detected a new COVID variant in South Africa that could be to blame for a recent sharp surge in cases, especially in Europe.\nU.S. markets were closed for Thanksgiving on Thursday and ended at 1 p.m. Eastern Time on Friday, three hours earlier than usual, and bond market trading ends at 2 p.m., an hour earlier than is typical.\nHow are stock-index futures trading?\nOn Wednesday, the Dow industrials fell 9.42 points to finish nearly flat at 35,804.38. The S&P 500 slipped 0.2% to close at 4,701.46, just 0.1% below its Nov. 18 record close of 4,704.54, according to Dow Jones Market Data. The Nasdaq Composite Index rose 0.4% to 15,84.23.\nWhat's driving the market?\nIt was an ugly day for stock investors during a thinly traded Black Friday session, which was susceptible to big swings on alarming news from public health officials who were assessing a new variant of the coronavirus that causes COVID-19.\nLate in the session, the World Health Organization's technical advisory group assigned the B. 1.1.529 variant of the virus the Greek letter omicron and declared it a \"variant of concern,\" as it did with the delta variant.\nFear of a new variant overshadowed the usual focus on U.S. Black Friday shopping day, which puts the focus on retailers as consumers shop for bargains.\nParticularly notable about the variant is the \"large number of mutations, some of which are concerning,\" the WHO group said in a statement. The mutations could make omicron more resistant to the current batch of vaccines.\nThe discovery of the new COVID strain was announced on Friday by South Africa's health minister Joe Phaahla. He said scientists were concerned because of its high number of mutations and the dramatic surge in infections the country had seen over the past four or five days.\n\"The pandemic and COVID variants remain one of the biggest risks to markets, and are likely to continue to inject volatility over the next year(s),\" wrote Keith Lerner, co-chief investment officer and chief market strategist at Truist Advisory Services, in a Friday note. \"It's hard to say at this point how lasting or impactful this latest variant will be for markets,\" the analyst wrote.\nThe omicron strain has been detected in Botswana and in Hong Kong in travelers who had visited South Africa.\n\"The one bull in the China shop that could truly derail the global recovery has always been a new strain of Covid-19 that swept the world and caused the reimposition of mass social retractions,\" said Jeffrey Halley, senior market analyst, at OANDA, in a note. \"All we know so far is the B. 1.1.529 is heavily mutated but markets are taking no chances.\"\n\"Just when you thought Covid was being controlled in a holiday shortened week,\" said Sam Stovall, chief investment strategist at CFRA Research, in emailed comments.\nTrading around the Thanksgiving holiday is often associated with lower trading volumes as traders typically wait until Monday to return to work. There was no U.S. economic data on the calendar for Friday.\nAfter new cases stabilized at 200 a day, South Africa reported more than 1,200 on Wednesday and 2,465 on Thursday.\nThe U.K. government is banning flights from South Africa along with five other African nations, effective Friday.\n\"Predictably, energy, travel related and financials are the leading decliners and treasuries are rallying,\" wrote Jay Hatfield, CEO and portfolio manager at Infrastructure Capital Management, in emailed comments on Friday.\n\"It makes sense to have a market significant correction given the high level of uncertainty,\" the money manager wrote.\n\"At this stage very little is known,\" Deutsche Bank strategists, led by Jim Reid, told clients in a note. \"Mutations are often less severe so we shouldn't jump to conclusions but there is clearly a lot of concern about this one. Also South Africa is one of the world leaders in sequencing so we are more likely to see this sort of news originate from there than many countries. Suffice to say at this stage no one in markets will have any idea which way this will go.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":888,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600070576,"gmtCreate":1638023352649,"gmtModify":1638023352846,"author":{"id":"3573948076022422","authorId":"3573948076022422","name":"Annie12345","avatar":"https://static.tigerbbs.com/b7529e308acffa5522a9e9690d9dcae6","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573948076022422","authorIdStr":"3573948076022422"},"themes":[],"htmlText":"Haiz","listText":"Haiz","text":"Haiz","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600070576","repostId":"2186344334","repostType":4,"repost":{"id":"2186344334","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1637967996,"share":"https://www.laohu8.com/m/news/2186344334?lang=&edition=full","pubTime":"2021-11-27 07:06","market":"hk","language":"en","title":"Dow plunges 905 points in Black Friday selloff, books worst day in over a year as WHO declares new COVID 'variant of concern'","url":"https://stock-news.laohu8.com/highlight/detail?id=2186344334","media":"Dow Jones","summary":"Dow notches worst day for blue chips since Oct. 28, 2020, FactSet data show\nU.S. stock benchmarks su","content":"<p>Dow notches worst day for blue chips since Oct. 28, 2020, FactSet data show</p>\n<p>U.S. stock benchmarks suffered withering losses on Friday as stock and commodity markets plunged, after scientists detected a new COVID variant in South Africa that could be to blame for a recent sharp surge in cases, especially in Europe.</p>\n<p>U.S. markets were closed for Thanksgiving on Thursday and ended at 1 p.m. Eastern Time on Friday, three hours earlier than usual, and bond market trading ends at 2 p.m., an hour earlier than is typical.</p>\n<p>How are stock-index futures trading?</p>\n<p>On Wednesday, the Dow industrials fell 9.42 points to finish nearly flat at 35,804.38. The S&P 500 slipped 0.2% to close at 4,701.46, just 0.1% below its Nov. 18 record close of 4,704.54, according to Dow Jones Market Data. The Nasdaq Composite Index rose 0.4% to 15,84.23.</p>\n<p>What's driving the market?</p>\n<p>It was an ugly day for stock investors during a thinly traded Black Friday session, which was susceptible to big swings on alarming news from public health officials who were assessing a new variant of the coronavirus that causes COVID-19.</p>\n<p>Late in the session, the World Health Organization's technical advisory group assigned the B. 1.1.529 variant of the virus the Greek letter omicron and declared it a \"variant of concern,\" as it did with the delta variant.</p>\n<p>Fear of a new variant overshadowed the usual focus on U.S. Black Friday shopping day, which puts the focus on retailers as consumers shop for bargains.</p>\n<p>Particularly notable about the variant is the \"large number of mutations, some of which are concerning,\" the WHO group said in a statement. The mutations could make omicron more resistant to the current batch of vaccines.</p>\n<p>The discovery of the new COVID strain was announced on Friday by South Africa's health minister Joe Phaahla. He said scientists were concerned because of its high number of mutations and the dramatic surge in infections the country had seen over the past four or five days.</p>\n<p>\"The pandemic and COVID variants remain <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the biggest risks to markets, and are likely to continue to inject volatility over the next year(s),\" wrote Keith Lerner, co-chief investment officer and chief market strategist at Truist Advisory Services, in a Friday note. \"It's hard to say at this point how lasting or impactful this latest variant will be for markets,\" the analyst wrote.</p>\n<p>The omicron strain has been detected in Botswana and in Hong Kong in travelers who had visited South Africa.</p>\n<p>\"The one bull in the China shop that could truly derail the global recovery has always been a new strain of Covid-19 that swept the world and caused the reimposition of mass social retractions,\" said Jeffrey Halley, senior market analyst, at OANDA, in a note. \"All we know so far is the B. 1.1.529 is heavily mutated but markets are taking no chances.\"</p>\n<p>\"Just when you thought Covid was being controlled in a holiday shortened week,\" said Sam Stovall, chief investment strategist at CFRA Research, in emailed comments.</p>\n<p>Trading around the Thanksgiving holiday is often associated with lower trading volumes as traders typically wait until Monday to return to work. There was no U.S. economic data on the calendar for Friday.</p>\n<p>After new cases stabilized at 200 a day, South Africa reported more than 1,200 on Wednesday and 2,465 on Thursday.</p>\n<p>The U.K. government is banning flights from South Africa along with five other African nations, effective Friday.</p>\n<p>\"Predictably, energy, travel related and financials are the leading decliners and treasuries are rallying,\" wrote Jay Hatfield, CEO and portfolio manager at Infrastructure Capital Management, in emailed comments on Friday.</p>\n<p>\"It makes sense to have a market significant correction given the high level of uncertainty,\" the money manager wrote.</p>\n<p>\"At this stage very little is known,\" Deutsche Bank strategists, led by Jim Reid, told clients in a note. \"Mutations are often less severe so we shouldn't jump to conclusions but there is clearly a lot of concern about this one. Also South Africa is one of the world leaders in sequencing so we are more likely to see this sort of news originate from there than many countries. Suffice to say at this stage no one in markets will have any idea which way this will go.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow plunges 905 points in Black Friday selloff, books worst day in over a year as WHO declares new COVID 'variant of concern'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow plunges 905 points in Black Friday selloff, books worst day in over a year as WHO declares new COVID 'variant of concern'\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-11-27 07:06</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dow notches worst day for blue chips since Oct. 28, 2020, FactSet data show</p>\n<p>U.S. stock benchmarks suffered withering losses on Friday as stock and commodity markets plunged, after scientists detected a new COVID variant in South Africa that could be to blame for a recent sharp surge in cases, especially in Europe.</p>\n<p>U.S. markets were closed for Thanksgiving on Thursday and ended at 1 p.m. Eastern Time on Friday, three hours earlier than usual, and bond market trading ends at 2 p.m., an hour earlier than is typical.</p>\n<p>How are stock-index futures trading?</p>\n<p>On Wednesday, the Dow industrials fell 9.42 points to finish nearly flat at 35,804.38. The S&P 500 slipped 0.2% to close at 4,701.46, just 0.1% below its Nov. 18 record close of 4,704.54, according to Dow Jones Market Data. The Nasdaq Composite Index rose 0.4% to 15,84.23.</p>\n<p>What's driving the market?</p>\n<p>It was an ugly day for stock investors during a thinly traded Black Friday session, which was susceptible to big swings on alarming news from public health officials who were assessing a new variant of the coronavirus that causes COVID-19.</p>\n<p>Late in the session, the World Health Organization's technical advisory group assigned the B. 1.1.529 variant of the virus the Greek letter omicron and declared it a \"variant of concern,\" as it did with the delta variant.</p>\n<p>Fear of a new variant overshadowed the usual focus on U.S. Black Friday shopping day, which puts the focus on retailers as consumers shop for bargains.</p>\n<p>Particularly notable about the variant is the \"large number of mutations, some of which are concerning,\" the WHO group said in a statement. The mutations could make omicron more resistant to the current batch of vaccines.</p>\n<p>The discovery of the new COVID strain was announced on Friday by South Africa's health minister Joe Phaahla. He said scientists were concerned because of its high number of mutations and the dramatic surge in infections the country had seen over the past four or five days.</p>\n<p>\"The pandemic and COVID variants remain <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the biggest risks to markets, and are likely to continue to inject volatility over the next year(s),\" wrote Keith Lerner, co-chief investment officer and chief market strategist at Truist Advisory Services, in a Friday note. \"It's hard to say at this point how lasting or impactful this latest variant will be for markets,\" the analyst wrote.</p>\n<p>The omicron strain has been detected in Botswana and in Hong Kong in travelers who had visited South Africa.</p>\n<p>\"The one bull in the China shop that could truly derail the global recovery has always been a new strain of Covid-19 that swept the world and caused the reimposition of mass social retractions,\" said Jeffrey Halley, senior market analyst, at OANDA, in a note. \"All we know so far is the B. 1.1.529 is heavily mutated but markets are taking no chances.\"</p>\n<p>\"Just when you thought Covid was being controlled in a holiday shortened week,\" said Sam Stovall, chief investment strategist at CFRA Research, in emailed comments.</p>\n<p>Trading around the Thanksgiving holiday is often associated with lower trading volumes as traders typically wait until Monday to return to work. There was no U.S. economic data on the calendar for Friday.</p>\n<p>After new cases stabilized at 200 a day, South Africa reported more than 1,200 on Wednesday and 2,465 on Thursday.</p>\n<p>The U.K. government is banning flights from South Africa along with five other African nations, effective Friday.</p>\n<p>\"Predictably, energy, travel related and financials are the leading decliners and treasuries are rallying,\" wrote Jay Hatfield, CEO and portfolio manager at Infrastructure Capital Management, in emailed comments on Friday.</p>\n<p>\"It makes sense to have a market significant correction given the high level of uncertainty,\" the money manager wrote.</p>\n<p>\"At this stage very little is known,\" Deutsche Bank strategists, led by Jim Reid, told clients in a note. \"Mutations are often less severe so we shouldn't jump to conclusions but there is clearly a lot of concern about this one. Also South Africa is one of the world leaders in sequencing so we are more likely to see this sort of news originate from there than many countries. Suffice to say at this stage no one in markets will have any idea which way this will go.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4554":"元宇宙及AR概念","BK4566":"资本集团","BK4525":"远程办公概念","BK4532":"文艺复兴科技持仓","BK4548":"巴美列捷福持仓","BK4528":"SaaS概念","BK4551":"寇图资本持仓","ZM":"Zoom","BK4535":"淡马锡持仓","PTON":"Peloton Interactive, Inc.","BK4505":"高瓴资本持仓","BK4190":"消闲用品","BK4023":"应用软件"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2186344334","content_text":"Dow notches worst day for blue chips since Oct. 28, 2020, FactSet data show\nU.S. stock benchmarks suffered withering losses on Friday as stock and commodity markets plunged, after scientists detected a new COVID variant in South Africa that could be to blame for a recent sharp surge in cases, especially in Europe.\nU.S. markets were closed for Thanksgiving on Thursday and ended at 1 p.m. Eastern Time on Friday, three hours earlier than usual, and bond market trading ends at 2 p.m., an hour earlier than is typical.\nHow are stock-index futures trading?\nOn Wednesday, the Dow industrials fell 9.42 points to finish nearly flat at 35,804.38. The S&P 500 slipped 0.2% to close at 4,701.46, just 0.1% below its Nov. 18 record close of 4,704.54, according to Dow Jones Market Data. The Nasdaq Composite Index rose 0.4% to 15,84.23.\nWhat's driving the market?\nIt was an ugly day for stock investors during a thinly traded Black Friday session, which was susceptible to big swings on alarming news from public health officials who were assessing a new variant of the coronavirus that causes COVID-19.\nLate in the session, the World Health Organization's technical advisory group assigned the B. 1.1.529 variant of the virus the Greek letter omicron and declared it a \"variant of concern,\" as it did with the delta variant.\nFear of a new variant overshadowed the usual focus on U.S. Black Friday shopping day, which puts the focus on retailers as consumers shop for bargains.\nParticularly notable about the variant is the \"large number of mutations, some of which are concerning,\" the WHO group said in a statement. The mutations could make omicron more resistant to the current batch of vaccines.\nThe discovery of the new COVID strain was announced on Friday by South Africa's health minister Joe Phaahla. He said scientists were concerned because of its high number of mutations and the dramatic surge in infections the country had seen over the past four or five days.\n\"The pandemic and COVID variants remain one of the biggest risks to markets, and are likely to continue to inject volatility over the next year(s),\" wrote Keith Lerner, co-chief investment officer and chief market strategist at Truist Advisory Services, in a Friday note. \"It's hard to say at this point how lasting or impactful this latest variant will be for markets,\" the analyst wrote.\nThe omicron strain has been detected in Botswana and in Hong Kong in travelers who had visited South Africa.\n\"The one bull in the China shop that could truly derail the global recovery has always been a new strain of Covid-19 that swept the world and caused the reimposition of mass social retractions,\" said Jeffrey Halley, senior market analyst, at OANDA, in a note. \"All we know so far is the B. 1.1.529 is heavily mutated but markets are taking no chances.\"\n\"Just when you thought Covid was being controlled in a holiday shortened week,\" said Sam Stovall, chief investment strategist at CFRA Research, in emailed comments.\nTrading around the Thanksgiving holiday is often associated with lower trading volumes as traders typically wait until Monday to return to work. There was no U.S. economic data on the calendar for Friday.\nAfter new cases stabilized at 200 a day, South Africa reported more than 1,200 on Wednesday and 2,465 on Thursday.\nThe U.K. government is banning flights from South Africa along with five other African nations, effective Friday.\n\"Predictably, energy, travel related and financials are the leading decliners and treasuries are rallying,\" wrote Jay Hatfield, CEO and portfolio manager at Infrastructure Capital Management, in emailed comments on Friday.\n\"It makes sense to have a market significant correction given the high level of uncertainty,\" the money manager wrote.\n\"At this stage very little is known,\" Deutsche Bank strategists, led by Jim Reid, told clients in a note. \"Mutations are often less severe so we shouldn't jump to conclusions but there is clearly a lot of concern about this one. Also South Africa is one of the world leaders in sequencing so we are more likely to see this sort of news originate from there than many countries. Suffice to say at this stage no one in markets will have any idea which way this will go.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":1068,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872622320,"gmtCreate":1637509764766,"gmtModify":1637509764996,"author":{"id":"3573948076022422","authorId":"3573948076022422","name":"Annie12345","avatar":"https://static.tigerbbs.com/b7529e308acffa5522a9e9690d9dcae6","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573948076022422","authorIdStr":"3573948076022422"},"themes":[],"htmlText":"Lol","listText":"Lol","text":"Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872622320","repostId":"1136453612","repostType":4,"repost":{"id":"1136453612","pubTimestamp":1637458211,"share":"https://www.laohu8.com/m/news/1136453612?lang=&edition=full","pubTime":"2021-11-21 09:30","market":"us","language":"en","title":"UBS Picks Former Morgan Stanley President Kelleher As chairman, Deutsche Bank Nominates Alexander Wynaendts As Next Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=1136453612","media":"Benzinga ","summary":"UBS Group has named former Morgan Stanley President Colm Kelleher as its new chairman.\nA day before,","content":"<p><b>UBS Group</b> has named former <b>Morgan Stanley</b> President <b>Colm Kelleher</b> as its new chairman.</p>\n<p>A day before,<b>Deutsche Bank</b> announced that it would nominate Dutch businessman <b>Alexander Wynaendts</b> as the next chairman of its supervisory board, following a turbulent decade for Germany’s largest lender.</p>\n<p>Kelleher will succeed Axel Weber as UBS’s chairman next year. He takes the leadership role having spent three decades at Morgan Stanley, where he served as chief financial officer before rising to the position of president.</p>\n<p>According to Reuters, UBS’s board had included former UniCredit Chief Executive Jean-Pierre Mustier in a shortlist of possible candidates.</p>\n<p>In October, UBS posted its highest quarterly profit over the past 11 years, with a 23% rise in fee income.</p>\n<p>Similarly, Wynaendts will replace Paul Achleitner at Deutsche Bank. The bank's shares have fallen more than 50% since Achleitner became chairman, primarily due to massive regulatory fines and repeated capital raisings.</p>\n<p>Wynaendts ran Dutch insurer Aegon NV for 12 years before leaving in 2020, and previously worked at ABN Amro’s investment banking and private banking units before joining Aegon in 1997.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UBS Picks Former Morgan Stanley President Kelleher As chairman, Deutsche Bank Nominates Alexander Wynaendts As Next Chairman</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUBS Picks Former Morgan Stanley President Kelleher As chairman, Deutsche Bank Nominates Alexander Wynaendts As Next Chairman\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-21 09:30 GMT+8 <a href=https://www.benzinga.com/news/21/11/24210567/ubs-picks-former-morgan-stanley-president-kelleher-as-chairman-deutsche-bank-nominates-alexander-wyn><strong>Benzinga </strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>UBS Group has named former Morgan Stanley President Colm Kelleher as its new chairman.\nA day before,Deutsche Bank announced that it would nominate Dutch businessman Alexander Wynaendts as the next ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/11/24210567/ubs-picks-former-morgan-stanley-president-kelleher-as-chairman-deutsche-bank-nominates-alexander-wyn\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UBS":"瑞银"},"source_url":"https://www.benzinga.com/news/21/11/24210567/ubs-picks-former-morgan-stanley-president-kelleher-as-chairman-deutsche-bank-nominates-alexander-wyn","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136453612","content_text":"UBS Group has named former Morgan Stanley President Colm Kelleher as its new chairman.\nA day before,Deutsche Bank announced that it would nominate Dutch businessman Alexander Wynaendts as the next chairman of its supervisory board, following a turbulent decade for Germany’s largest lender.\nKelleher will succeed Axel Weber as UBS’s chairman next year. He takes the leadership role having spent three decades at Morgan Stanley, where he served as chief financial officer before rising to the position of president.\nAccording to Reuters, UBS’s board had included former UniCredit Chief Executive Jean-Pierre Mustier in a shortlist of possible candidates.\nIn October, UBS posted its highest quarterly profit over the past 11 years, with a 23% rise in fee income.\nSimilarly, Wynaendts will replace Paul Achleitner at Deutsche Bank. The bank's shares have fallen more than 50% since Achleitner became chairman, primarily due to massive regulatory fines and repeated capital raisings.\nWynaendts ran Dutch insurer Aegon NV for 12 years before leaving in 2020, and previously worked at ABN Amro’s investment banking and private banking units before joining Aegon in 1997.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1311,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873952288,"gmtCreate":1636849821806,"gmtModify":1636849821984,"author":{"id":"3573948076022422","authorId":"3573948076022422","name":"Annie12345","avatar":"https://static.tigerbbs.com/b7529e308acffa5522a9e9690d9dcae6","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573948076022422","authorIdStr":"3573948076022422"},"themes":[],"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873952288","repostId":"1129004768","repostType":4,"repost":{"id":"1129004768","pubTimestamp":1636764434,"share":"https://www.laohu8.com/m/news/1129004768?lang=&edition=full","pubTime":"2021-11-13 08:47","market":"us","language":"en","title":"Apple: The Bear Argument, And Why It's Wrong","url":"https://stock-news.laohu8.com/highlight/detail?id=1129004768","media":"Seeking Alpha","summary":"Apple has failed to stay above $150 per share for long, and bears are starting to pay attention to the recent weakness in price.I list a couple of the most popular bearish arguments, and explain why I believe that they are either short-sighted or most likely incorrect.Maybe AAPL is not the same pound-the-table buy, but I continue to think that this is a stock to own today through the next several years.This may also help to explain, in part, why Apple's revenues in Greater China shot through the","content":"<p><b>Summary</b></p>\n<ul>\n <li>Apple has failed to stay above $150 per share for long, and bears are starting to pay attention to the recent weakness in price.</li>\n <li>I list a couple of the most popular bearish arguments, and explain why I believe that they are either short-sighted or most likely incorrect.</li>\n <li>Maybe AAPL is not the same pound-the-table buy, but I continue to think that this is a stock to own today through the next several years.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4bc955cc5d27328c3b89b327b9368d27\" tg-width=\"1536\" tg-height=\"1020\" width=\"100%\" height=\"auto\"><span>kmwphotography/iStock via Getty Images</span></p>\n<p>With Apple (AAPL) once again failing to make fresh all-time highs, now down around 6% from the peak and dipping closer towards key moving-average support, bears have started to pay attention. Still, I think that the case for selling (or shorting) this stock does not hold much water in the long term, and I believe that bears will ultimately tire of swimming against the current.</p>\n<p>Below, I list the most common few reasons why one might want to dump or stay away from Apple shares – and why I think that the bearish case is either short-sighted or most likely incorrect.</p>\n<p><b>Key risk #1: drop-off in demand</b></p>\n<p>Not many analysts and portfolio managers have been vocal about avoiding or selling Apple. Experts like New Street's Pierre Ferragu and Satori Fund's Dan Niles are the few that come to mind, and their theses seem to align pretty well with every other bearish call on AAPL that I have seen recently.</p>\n<p>The first common reason to sell the stock is often phrased in different ways, but can effectively be summarized as follows: Apple's financial results in the near term should suffer from demand that has already turned into revenues in calendar 2020, during the thick of the pandemic and stay-at-home consumption wave. This is particularly true following the launch of the iPhone 13 that some (including legendary Apple founder Steve Wozniak) see as merely a minor upgrade from the previous model.</p>\n<p>I see the concern here, especially considering that Apple will start to face unsurmountable iPhone comps in the holidays and post-holiday quarters – see graph below. But the same chart also shows that there seemed to exist quite a bit of pent-up demand over the many quarters that preceded the iPhone 12 launch. One possible justification for this shift in sales from fiscal 2019-2020 to 2021 is Apple's late entry into the 5G space. Consumers that are loyal to or just prefer the iOS device probably waited patiently to upgrade or switch, and then they did it all at once.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7dc677f0a1c77dd39f40b4cc99c6fc15\" tg-width=\"460\" tg-height=\"322\" width=\"100%\" height=\"auto\"><span>Source: DM Martins Research, data from company reports</span></p>\n<p>This may also help to explain, in part, why Apple's revenues in Greater China shot through the roof in the past 6 to 12 months. With the country's 5G infrastructure being further developed, owning a device that can handle the faster speeds probably makes most sense. Sales in the region had been lackluster to say the least since 2015, and dropped YOY by as much as 29% in fiscal Q4 of 2020. In the past three quarters, however, revenues climbed by at least 57% in each period.</p>\n<p>In the end, over the last 12 quarters – i.e. roughly the useful life of the average iPhone – Apple's smartphone sales have risen by only 4.8% per year. Considering that ASP (average selling price) has likely increased during the period, this figure barely represents any meaningful growth in device shipments over a full cycle. Therefore, to think that demand for Apple's products will fall off a cliff next seems like a stretch, especially if one also considers chip innovation and design updates in Mac and iPad.</p>\n<p><b>Key risk #2: valuation</b></p>\n<p>The other key risk of investing in Apple that is often brought up is valuation. Dan Niles, mentioned above, suggests that a next-year P/E of 26 times might not even be the biggest deal. The problem is that this multiple looks too rich against growth expectations that are modest.Analysts expect Apple's EPS to rise by only 4% per year through fiscal 2025. Alphabet (GOOG)(GOOGL), valued at a similar earnings multiple, is expected to drive earnings 16% higher per year over a similar period.</p>\n<p>That, in my view, is a more reasonable bearish argument. Per my estimates, Apple is by far the stock with the highest PEG ratio (P/E over long-term EPS growth) of 6.5 times. Amazon (AMZN) is a very distant second on this metric, at 2.3 times. But even here, I see a good argument to be made in favor of Apple.</p>\n<p>First, the company has been proving to be a powerful gatekeeper in the tech world. Here is one example: the first, most blatant sign that Apple's iOS privacy policy changes in the summer have been hurting social media companies and their financial statements led to the Nasdaqe rasing $120 billion in market value in a matter of minutes – most of which coming from internet stocks. Should one be expected to pay a premium for a stock in the face of such market control? I would say so.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0946db3f3bc62569a56f2dbe2aa75922\" tg-width=\"635\" tg-height=\"417\" width=\"100%\" height=\"auto\"><span>Data by YCharts</span></p>\n<p>Also, as the chart above depicts, Apple's forward-year P/E has certainly expanded relative to what it used to be a few years ago. But the multi-year move higher seems consistent with (1) a wave of increased demand for Apple's products and services, (2) better margins, (3) a drop in interest rates in 2020, and (4) a broad stock market that has become generally more expensive. Compared to how AAPL traded only about three months ago, P/E has in fact dipped about three turns and returned to early 2021 levels.</p>\n<p><b>Key risk #3: lack of positive catalysts</b></p>\n<p>The next risk to investing in Apple that is often cited are short-term catalysts. The iPhone 13 was announced a few weeks ago, and so has the refreshed lineup of MacBook Pro devices equipped with the new M1 Pro and Max chips. Fiscal fourth quarter earnings is also in the rearview mirror. In fact, I think that the drop off in relevant Apple news in the fourth quarter correlates well with a stock that, seasonally, tends to perform worse in the November-to-January period. Bears may also argue that, with a few quarters of tough comps ahead, investors might have a hard time finding reasons to buy AAPL in the next few months.</p>\n<p>But here, I believe that a bit of patience is warranted. First, the recent malaise in share price alone may be enough to attract new money from investors looking for a good deal on a high-quality stock. But more importantly, longer-term catalysts are likely to make more of a difference on share price and financial performance over the next, say, five years.</p>\n<p>I have previously talked in more detail about two catalysts that quickly come to mind. I doubt that much upside from initiatives like mixed reality and autonomous vehicle has been factored into analysts' financial models – and hence, properly priced into the stock. Because Apple is run by a conservative team of executives, I bet that both massive growth opportunities will be pursued if and when they are accretive to the company's earnings. They should, therefore, serve as the key catalysts driving long-term growth expectations (which is relevant for risk #1 above) and share price higher.</p>\n<p><b>In summary</b></p>\n<p>Apple may not be the same pound-the-table opportunity that I believed it to be in February 2021 or, better yet,in April 2018 – in both cases, I believed that shares had sold off for no good reason. But I continue to think that AAPL is a stock to own today through the next several years, especially now that the earnings multiple has started to rerate towards year-ago levels. Should Apple continue to head lower in the near term, the pullback (assuming no meaningful change in business fundamentals) would present an even better chance to buy.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple: The Bear Argument, And Why It's Wrong</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple: The Bear Argument, And Why It's Wrong\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-13 08:47 GMT+8 <a href=https://seekingalpha.com/article/4468890-apple-the-bear-argument-and-why-its-wrong><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nApple has failed to stay above $150 per share for long, and bears are starting to pay attention to the recent weakness in price.\nI list a couple of the most popular bearish arguments, and ...</p>\n\n<a href=\"https://seekingalpha.com/article/4468890-apple-the-bear-argument-and-why-its-wrong\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://seekingalpha.com/article/4468890-apple-the-bear-argument-and-why-its-wrong","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129004768","content_text":"Summary\n\nApple has failed to stay above $150 per share for long, and bears are starting to pay attention to the recent weakness in price.\nI list a couple of the most popular bearish arguments, and explain why I believe that they are either short-sighted or most likely incorrect.\nMaybe AAPL is not the same pound-the-table buy, but I continue to think that this is a stock to own today through the next several years.\n\nkmwphotography/iStock via Getty Images\nWith Apple (AAPL) once again failing to make fresh all-time highs, now down around 6% from the peak and dipping closer towards key moving-average support, bears have started to pay attention. Still, I think that the case for selling (or shorting) this stock does not hold much water in the long term, and I believe that bears will ultimately tire of swimming against the current.\nBelow, I list the most common few reasons why one might want to dump or stay away from Apple shares – and why I think that the bearish case is either short-sighted or most likely incorrect.\nKey risk #1: drop-off in demand\nNot many analysts and portfolio managers have been vocal about avoiding or selling Apple. Experts like New Street's Pierre Ferragu and Satori Fund's Dan Niles are the few that come to mind, and their theses seem to align pretty well with every other bearish call on AAPL that I have seen recently.\nThe first common reason to sell the stock is often phrased in different ways, but can effectively be summarized as follows: Apple's financial results in the near term should suffer from demand that has already turned into revenues in calendar 2020, during the thick of the pandemic and stay-at-home consumption wave. This is particularly true following the launch of the iPhone 13 that some (including legendary Apple founder Steve Wozniak) see as merely a minor upgrade from the previous model.\nI see the concern here, especially considering that Apple will start to face unsurmountable iPhone comps in the holidays and post-holiday quarters – see graph below. But the same chart also shows that there seemed to exist quite a bit of pent-up demand over the many quarters that preceded the iPhone 12 launch. One possible justification for this shift in sales from fiscal 2019-2020 to 2021 is Apple's late entry into the 5G space. Consumers that are loyal to or just prefer the iOS device probably waited patiently to upgrade or switch, and then they did it all at once.\nSource: DM Martins Research, data from company reports\nThis may also help to explain, in part, why Apple's revenues in Greater China shot through the roof in the past 6 to 12 months. With the country's 5G infrastructure being further developed, owning a device that can handle the faster speeds probably makes most sense. Sales in the region had been lackluster to say the least since 2015, and dropped YOY by as much as 29% in fiscal Q4 of 2020. In the past three quarters, however, revenues climbed by at least 57% in each period.\nIn the end, over the last 12 quarters – i.e. roughly the useful life of the average iPhone – Apple's smartphone sales have risen by only 4.8% per year. Considering that ASP (average selling price) has likely increased during the period, this figure barely represents any meaningful growth in device shipments over a full cycle. Therefore, to think that demand for Apple's products will fall off a cliff next seems like a stretch, especially if one also considers chip innovation and design updates in Mac and iPad.\nKey risk #2: valuation\nThe other key risk of investing in Apple that is often brought up is valuation. Dan Niles, mentioned above, suggests that a next-year P/E of 26 times might not even be the biggest deal. The problem is that this multiple looks too rich against growth expectations that are modest.Analysts expect Apple's EPS to rise by only 4% per year through fiscal 2025. Alphabet (GOOG)(GOOGL), valued at a similar earnings multiple, is expected to drive earnings 16% higher per year over a similar period.\nThat, in my view, is a more reasonable bearish argument. Per my estimates, Apple is by far the stock with the highest PEG ratio (P/E over long-term EPS growth) of 6.5 times. Amazon (AMZN) is a very distant second on this metric, at 2.3 times. But even here, I see a good argument to be made in favor of Apple.\nFirst, the company has been proving to be a powerful gatekeeper in the tech world. Here is one example: the first, most blatant sign that Apple's iOS privacy policy changes in the summer have been hurting social media companies and their financial statements led to the Nasdaqe rasing $120 billion in market value in a matter of minutes – most of which coming from internet stocks. Should one be expected to pay a premium for a stock in the face of such market control? I would say so.\nData by YCharts\nAlso, as the chart above depicts, Apple's forward-year P/E has certainly expanded relative to what it used to be a few years ago. But the multi-year move higher seems consistent with (1) a wave of increased demand for Apple's products and services, (2) better margins, (3) a drop in interest rates in 2020, and (4) a broad stock market that has become generally more expensive. Compared to how AAPL traded only about three months ago, P/E has in fact dipped about three turns and returned to early 2021 levels.\nKey risk #3: lack of positive catalysts\nThe next risk to investing in Apple that is often cited are short-term catalysts. The iPhone 13 was announced a few weeks ago, and so has the refreshed lineup of MacBook Pro devices equipped with the new M1 Pro and Max chips. Fiscal fourth quarter earnings is also in the rearview mirror. In fact, I think that the drop off in relevant Apple news in the fourth quarter correlates well with a stock that, seasonally, tends to perform worse in the November-to-January period. Bears may also argue that, with a few quarters of tough comps ahead, investors might have a hard time finding reasons to buy AAPL in the next few months.\nBut here, I believe that a bit of patience is warranted. First, the recent malaise in share price alone may be enough to attract new money from investors looking for a good deal on a high-quality stock. But more importantly, longer-term catalysts are likely to make more of a difference on share price and financial performance over the next, say, five years.\nI have previously talked in more detail about two catalysts that quickly come to mind. I doubt that much upside from initiatives like mixed reality and autonomous vehicle has been factored into analysts' financial models – and hence, properly priced into the stock. Because Apple is run by a conservative team of executives, I bet that both massive growth opportunities will be pursued if and when they are accretive to the company's earnings. They should, therefore, serve as the key catalysts driving long-term growth expectations (which is relevant for risk #1 above) and share price higher.\nIn summary\nApple may not be the same pound-the-table opportunity that I believed it to be in February 2021 or, better yet,in April 2018 – in both cases, I believed that shares had sold off for no good reason. But I continue to think that AAPL is a stock to own today through the next several years, especially now that the earnings multiple has started to rerate towards year-ago levels. Should Apple continue to head lower in the near term, the pullback (assuming no meaningful change in business fundamentals) would present an even better chance to buy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":761,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873009947,"gmtCreate":1636783648651,"gmtModify":1636783648828,"author":{"id":"3573948076022422","authorId":"3573948076022422","name":"Annie12345","avatar":"https://static.tigerbbs.com/b7529e308acffa5522a9e9690d9dcae6","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573948076022422","authorIdStr":"3573948076022422"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/873009947","repostId":"1102251183","repostType":4,"repost":{"id":"1102251183","pubTimestamp":1636772424,"share":"https://www.laohu8.com/m/news/1102251183?lang=&edition=full","pubTime":"2021-11-13 11:00","market":"us","language":"en","title":"Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.","url":"https://stock-news.laohu8.com/highlight/detail?id=1102251183","media":"Barrons","summary":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo","content":"<p>Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p>\n<p>“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p>\n<p>Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p>\n<p>Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p>\n<p>In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p>\n<p>The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p>\n<p>Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).</p>\n<p>The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p>\n<p>The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p>\n<p>The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p>\n<p>While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p>\n<p>In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p>\n<p>The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p>\n<p>“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p>\n<p>Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p>\n<p>“[Pfizer’s] pharmaceutical R&D is better than people had thought.”</p>\n<p>The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p>\n<p>“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p>\n<p>Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).</p>\n<p>“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p>\n<p>Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p>\n<p>“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p>\n<p>That makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p>\n<p>Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p>\n<p>Moderna shares are down more than 40% over the past three months.</p>\n<p>As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p>\n<p>When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p>\n<p>That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p>\n<p>Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p>\n<p>Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p>\n<p>An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-13 11:00 GMT+8 <a href=https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that...</p>\n\n<a href=\"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102251183","content_text":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.\n“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.\nTwo years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.\nBourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.\nIn a cover story in November 2019, Barron’s argued that Bourla and Dolsten could pull it off.\nThe new antiviral data reaffirms the case for Pfizer that Barron’s made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.\nPfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).\nThe Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.\nThe worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.\nThe success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.\nWhile Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.\nIn the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.\nThe antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.\n“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.\nDolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.\n“[Pfizer’s] pharmaceutical R&D is better than people had thought.”\nThe protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.\n“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.\nPfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).\n“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.\nChen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.\n“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”\nThat makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.\nBiden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”\nModerna shares are down more than 40% over the past three months.\nAs the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling Barron’s that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.\nWhen it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.\nThat contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.\nDolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”\nSuch a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.\nAn aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.","news_type":1},"isVote":1,"tweetType":1,"viewCount":704,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879342797,"gmtCreate":1636685219229,"gmtModify":1636685325469,"author":{"id":"3573948076022422","authorId":"3573948076022422","name":"Annie12345","avatar":"https://static.tigerbbs.com/b7529e308acffa5522a9e9690d9dcae6","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573948076022422","authorIdStr":"3573948076022422"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/879342797","repostId":"1179335408","repostType":4,"repost":{"id":"1179335408","pubTimestamp":1636683914,"share":"https://www.laohu8.com/m/news/1179335408?lang=&edition=full","pubTime":"2021-11-12 10:25","market":"us","language":"en","title":"Goldman Sachs builds thematic ETF lineup with three new disruptive funds","url":"https://stock-news.laohu8.com/highlight/detail?id=1179335408","media":"seeking alpha","summary":"Goldman Sachs(NYSE:GS)built out its thematic ETF lineup with the launch Thursday of three new funds ","content":"<ul>\n <li><a href=\"https://laohu8.com/S/GS\">Goldman Sachs</a>(NYSE:GS)built out its thematic ETF lineup with the launch Thursday of three new funds -- the Goldman Sachs Future Consumer <a href=\"https://laohu8.com/S/EQR\">Equity</a> ETF(NYSEARCA:GBUY), Goldman Sachs Future Health Care Equity ETF(NYSEARCA:GDOC)and the Goldman Sachs Future Real Estate and Infrastructure Equity ETF(NYSEARCA:GREI).</li>\n <li>All three ETFs trade on the <a href=\"https://laohu8.com/S/NWY\">New York</a> Stock Exchange and come with a 0.75% expense ratio. Below is a deeper dive into each:</li>\n</ul>\n<p><b>Goldman Sachs Future Consumer Equity ETF</b></p>\n<ul>\n <li>The Goldman Sachs Future Consumer Equity ETF (GBUY) provides exposure for individuals to the future of consumers.</li>\n <li>The fund invests in companies that align with Millennial and Gen Z's interests, as they're some of the most influential and disruptive consumers in the market.</li>\n <li>From a holdings standpoint, the fund comes with 45 positions and has as top holdings Amazon(NASDAQ:AMZN)weighted at 6.3%, <a href=\"https://laohu8.com/S/GOOG\">Alphabet</a>(NASDAQ:GOOG)at 5.3% and <a href=\"https://laohu8.com/S/SE\">Sea Ltd</a>.(NYSE:SE)weighted at 3.2%.</li>\n <li>GBUY ended the day -0.33%.</li>\n</ul>\n<p><b>Goldman Sachs Future Health Care Equity ETF</b></p>\n<ul>\n <li>The Goldman Sachs Future Health Care Equity ETF (GDOC) gives market participants the ability to invest in the rapidly changing healthcare sector.</li>\n <li>The ETF provides access to businesses involved in the disruption and innovation aspects of technology firms within healthcare.</li>\n <li>Holdings-wise, GDOC has 63 unique positionsthat are led by Eli Lilly(NYSE:LLY)weighted at 5%, <a href=\"https://laohu8.com/S/ISRG\">Intuitive Surgical</a>(NASDAQ:ISRG)at 3.8% and <a href=\"https://laohu8.com/S/PKI\">PerkinElmer</a>(NYSE:PKI)weighted at 3.8%.</li>\n <li>GDOC ended its first trading day +0.04%.</li>\n</ul>\n<p><b>Goldman Sachs Future Real Estate and Infrastructure Equity ETF</b></p>\n<ul>\n <li>The Goldman Sachs Future Real Estate and Infrastructure Equity ETF (GREI) provides exposure to the unique attributes of real estate and infrastructure.</li>\n <li>The fund focuses on firms that offer strong growth potential, low correlations to traditional asset classes and inflation-hedging benefits while being on the right side of disruption.</li>\n <li>GREI comes to market with 46 holdings and has top positions in Vinci SA(OTCPK:VCISF)weighted at 4.8%, <a href=\"https://laohu8.com/S/AMT\">American Tower</a> Corp.(NYSE:AMT)at 4.8%, and <a href=\"https://laohu8.com/S/NHLD\">National</a> Grid(NYSE:NGG)at 4.6%.</li>\n <li>GREI finished Thursday +0.13%.</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs builds thematic ETF lineup with three new disruptive funds</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs builds thematic ETF lineup with three new disruptive funds\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-12 10:25 GMT+8 <a href=https://seekingalpha.com/news/3769667-goldman-sachs-builds-out-thematic-etf-lineup-with-three-new-disruptive-funds><strong>seeking alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs(NYSE:GS)built out its thematic ETF lineup with the launch Thursday of three new funds -- the Goldman Sachs Future Consumer Equity ETF(NYSEARCA:GBUY), Goldman Sachs Future Health Care ...</p>\n\n<a href=\"https://seekingalpha.com/news/3769667-goldman-sachs-builds-out-thematic-etf-lineup-with-three-new-disruptive-funds\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GS":"高盛"},"source_url":"https://seekingalpha.com/news/3769667-goldman-sachs-builds-out-thematic-etf-lineup-with-three-new-disruptive-funds","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1179335408","content_text":"Goldman Sachs(NYSE:GS)built out its thematic ETF lineup with the launch Thursday of three new funds -- the Goldman Sachs Future Consumer Equity ETF(NYSEARCA:GBUY), Goldman Sachs Future Health Care Equity ETF(NYSEARCA:GDOC)and the Goldman Sachs Future Real Estate and Infrastructure Equity ETF(NYSEARCA:GREI).\nAll three ETFs trade on the New York Stock Exchange and come with a 0.75% expense ratio. Below is a deeper dive into each:\n\nGoldman Sachs Future Consumer Equity ETF\n\nThe Goldman Sachs Future Consumer Equity ETF (GBUY) provides exposure for individuals to the future of consumers.\nThe fund invests in companies that align with Millennial and Gen Z's interests, as they're some of the most influential and disruptive consumers in the market.\nFrom a holdings standpoint, the fund comes with 45 positions and has as top holdings Amazon(NASDAQ:AMZN)weighted at 6.3%, Alphabet(NASDAQ:GOOG)at 5.3% and Sea Ltd.(NYSE:SE)weighted at 3.2%.\nGBUY ended the day -0.33%.\n\nGoldman Sachs Future Health Care Equity ETF\n\nThe Goldman Sachs Future Health Care Equity ETF (GDOC) gives market participants the ability to invest in the rapidly changing healthcare sector.\nThe ETF provides access to businesses involved in the disruption and innovation aspects of technology firms within healthcare.\nHoldings-wise, GDOC has 63 unique positionsthat are led by Eli Lilly(NYSE:LLY)weighted at 5%, Intuitive Surgical(NASDAQ:ISRG)at 3.8% and PerkinElmer(NYSE:PKI)weighted at 3.8%.\nGDOC ended its first trading day +0.04%.\n\nGoldman Sachs Future Real Estate and Infrastructure Equity ETF\n\nThe Goldman Sachs Future Real Estate and Infrastructure Equity ETF (GREI) provides exposure to the unique attributes of real estate and infrastructure.\nThe fund focuses on firms that offer strong growth potential, low correlations to traditional asset classes and inflation-hedging benefits while being on the right side of disruption.\nGREI comes to market with 46 holdings and has top positions in Vinci SA(OTCPK:VCISF)weighted at 4.8%, American Tower Corp.(NYSE:AMT)at 4.8%, and National Grid(NYSE:NGG)at 4.6%.\nGREI finished Thursday +0.13%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":263,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":609468359,"gmtCreate":1638318245027,"gmtModify":1638318245250,"author":{"id":"3573948076022422","authorId":"3573948076022422","name":"Annie12345","avatar":"https://static.tigerbbs.com/b7529e308acffa5522a9e9690d9dcae6","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573948076022422","idStr":"3573948076022422"},"themes":[],"htmlText":"Hopefully today turn green ","listText":"Hopefully today turn green ","text":"Hopefully today turn green","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609468359","repostId":"1129769141","repostType":4,"repost":{"id":"1129769141","pubTimestamp":1638317199,"share":"https://www.laohu8.com/m/news/1129769141?lang=&edition=full","pubTime":"2021-12-01 08:06","market":"us","language":"en","title":"Oversold Singapore Bourse Called Lower Again","url":"https://stock-news.laohu8.com/highlight/detail?id=1129769141","media":"RTTNews","summary":"The Singapore stock market has finished lower in six straight trading days, sinking almost 200 point","content":"<p>The Singapore stock market has finished lower in six straight trading days, sinking almost 200 points or 6.4 percent along the way. The Straits Times Index now sits just above the 3,040-point plateau and it's got another weak lead for Wednesday's trade.</p>\n<p>The global forecast for the Asian markets suggests consolidation on continued COVID-19 worries and concerns over the outlook for interest rates. The European and U.S. markets were down and the Asian markets figure to open in similar fashion.</p>\n<p>The STI finished sharply lower on Tuesday with damage across the board, especially from the financials and industrials.</p>\n<p>For the day, the index plunged 79.29 points or 2.54 percent to finish at the daily low of 3,041.29 after peaking at 3,129.54. Volume was 3.22 billion shares worth 3.89 billion Singapore dollars. There were 338 decliners and 172 gainers.</p>\n<p>Among the actives, Ascendas REIT slumped 2.34 percent, while CapitaLand Integrated Commercial Trust and Jardine Cycle both fell 1.40 percent, City Developments added 0.29 percent, Comfort DelGro plummeted 4.20 percent, Dairy Farm International and Thai Beverage both weakened 2.19 percent, DBS Group declined 2.99 percent, Genting Singapore skidded 2.53 percent, Keppel Corp sank 2.11 percent, Mapletree Commercial Trust stumbled 2.39 percent, Mapletree Logistics Trust lost 1.87 percent, Oversea-Chinese Banking Corporation surrendered 3.17 percent, SATS retreated 2.56 percent, SembCorp Industries plunged 4.08 percent, Singapore Airlines slid 0.81 percent, Singapore Exchange tumbled 3.25 percent, Singapore Press Holdings eased 0.43 percent, Singapore Technologies Engineering was down 0.78 percent, SingTel dropped 2.07 percent, United Overseas Bank tanked 4.00 percent, Wilmar International shed 1.91 percent and Yangzijiang Shipbuilding was unchanged.</p>\n<p>The lead from Wall Street is broadly negative as the major averages opened lower on Tuesday and remained largely under water throughout the trading day.</p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oversold Singapore Bourse Called Lower Again</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOversold Singapore Bourse Called Lower Again\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-01 08:06 GMT+8 <a href=https://www.rttnews.com/3245823/oversold-singapore-bourse-called-lower-again.aspx?type=acom><strong>RTTNews</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Singapore stock market has finished lower in six straight trading days, sinking almost 200 points or 6.4 percent along the way. The Straits Times Index now sits just above the 3,040-point plateau ...</p>\n\n<a href=\"https://www.rttnews.com/3245823/oversold-singapore-bourse-called-lower-again.aspx?type=acom\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"O39.SI":"华侨银行","C6L.SI":"新加坡航空公司","STI.SI":"富时新加坡海峡指数","D05.SI":"星展集团控股","BVA.SI":"顶级手套有限公司"},"source_url":"https://www.rttnews.com/3245823/oversold-singapore-bourse-called-lower-again.aspx?type=acom","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129769141","content_text":"The Singapore stock market has finished lower in six straight trading days, sinking almost 200 points or 6.4 percent along the way. The Straits Times Index now sits just above the 3,040-point plateau and it's got another weak lead for Wednesday's trade.\nThe global forecast for the Asian markets suggests consolidation on continued COVID-19 worries and concerns over the outlook for interest rates. The European and U.S. markets were down and the Asian markets figure to open in similar fashion.\nThe STI finished sharply lower on Tuesday with damage across the board, especially from the financials and industrials.\nFor the day, the index plunged 79.29 points or 2.54 percent to finish at the daily low of 3,041.29 after peaking at 3,129.54. Volume was 3.22 billion shares worth 3.89 billion Singapore dollars. There were 338 decliners and 172 gainers.\nAmong the actives, Ascendas REIT slumped 2.34 percent, while CapitaLand Integrated Commercial Trust and Jardine Cycle both fell 1.40 percent, City Developments added 0.29 percent, Comfort DelGro plummeted 4.20 percent, Dairy Farm International and Thai Beverage both weakened 2.19 percent, DBS Group declined 2.99 percent, Genting Singapore skidded 2.53 percent, Keppel Corp sank 2.11 percent, Mapletree Commercial Trust stumbled 2.39 percent, Mapletree Logistics Trust lost 1.87 percent, Oversea-Chinese Banking Corporation surrendered 3.17 percent, SATS retreated 2.56 percent, SembCorp Industries plunged 4.08 percent, Singapore Airlines slid 0.81 percent, Singapore Exchange tumbled 3.25 percent, Singapore Press Holdings eased 0.43 percent, Singapore Technologies Engineering was down 0.78 percent, SingTel dropped 2.07 percent, United Overseas Bank tanked 4.00 percent, Wilmar International shed 1.91 percent and Yangzijiang Shipbuilding was unchanged.\nThe lead from Wall Street is broadly negative as the major averages opened lower on Tuesday and remained largely under water throughout the trading day.","news_type":1},"isVote":1,"tweetType":1,"viewCount":699,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873009947,"gmtCreate":1636783648651,"gmtModify":1636783648828,"author":{"id":"3573948076022422","authorId":"3573948076022422","name":"Annie12345","avatar":"https://static.tigerbbs.com/b7529e308acffa5522a9e9690d9dcae6","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573948076022422","idStr":"3573948076022422"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/873009947","repostId":"1102251183","repostType":4,"repost":{"id":"1102251183","pubTimestamp":1636772424,"share":"https://www.laohu8.com/m/news/1102251183?lang=&edition=full","pubTime":"2021-11-13 11:00","market":"us","language":"en","title":"Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.","url":"https://stock-news.laohu8.com/highlight/detail?id=1102251183","media":"Barrons","summary":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo","content":"<p>Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p>\n<p>“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p>\n<p>Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p>\n<p>Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p>\n<p>In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p>\n<p>The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p>\n<p>Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).</p>\n<p>The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p>\n<p>The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p>\n<p>The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p>\n<p>While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p>\n<p>In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p>\n<p>The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p>\n<p>“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p>\n<p>Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p>\n<p>“[Pfizer’s] pharmaceutical R&D is better than people had thought.”</p>\n<p>The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p>\n<p>“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p>\n<p>Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).</p>\n<p>“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p>\n<p>Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p>\n<p>“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p>\n<p>That makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p>\n<p>Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p>\n<p>Moderna shares are down more than 40% over the past three months.</p>\n<p>As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p>\n<p>When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p>\n<p>That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p>\n<p>Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p>\n<p>Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p>\n<p>An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-13 11:00 GMT+8 <a href=https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that...</p>\n\n<a href=\"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102251183","content_text":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.\n“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.\nTwo years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.\nBourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.\nIn a cover story in November 2019, Barron’s argued that Bourla and Dolsten could pull it off.\nThe new antiviral data reaffirms the case for Pfizer that Barron’s made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.\nPfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).\nThe Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.\nThe worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.\nThe success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.\nWhile Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.\nIn the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.\nThe antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.\n“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.\nDolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.\n“[Pfizer’s] pharmaceutical R&D is better than people had thought.”\nThe protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.\n“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.\nPfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).\n“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.\nChen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.\n“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”\nThat makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.\nBiden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”\nModerna shares are down more than 40% over the past three months.\nAs the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling Barron’s that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.\nWhen it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.\nThat contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.\nDolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”\nSuch a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.\nAn aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.","news_type":1},"isVote":1,"tweetType":1,"viewCount":704,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600070485,"gmtCreate":1638023358779,"gmtModify":1638023358976,"author":{"id":"3573948076022422","authorId":"3573948076022422","name":"Annie12345","avatar":"https://static.tigerbbs.com/b7529e308acffa5522a9e9690d9dcae6","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573948076022422","idStr":"3573948076022422"},"themes":[],"htmlText":"O","listText":"O","text":"O","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/600070485","repostId":"2186344334","repostType":4,"repost":{"id":"2186344334","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1637967996,"share":"https://www.laohu8.com/m/news/2186344334?lang=&edition=full","pubTime":"2021-11-27 07:06","market":"hk","language":"en","title":"Dow plunges 905 points in Black Friday selloff, books worst day in over a year as WHO declares new COVID 'variant of concern'","url":"https://stock-news.laohu8.com/highlight/detail?id=2186344334","media":"Dow Jones","summary":"Dow notches worst day for blue chips since Oct. 28, 2020, FactSet data show\nU.S. stock benchmarks su","content":"<p>Dow notches worst day for blue chips since Oct. 28, 2020, FactSet data show</p>\n<p>U.S. stock benchmarks suffered withering losses on Friday as stock and commodity markets plunged, after scientists detected a new COVID variant in South Africa that could be to blame for a recent sharp surge in cases, especially in Europe.</p>\n<p>U.S. markets were closed for Thanksgiving on Thursday and ended at 1 p.m. Eastern Time on Friday, three hours earlier than usual, and bond market trading ends at 2 p.m., an hour earlier than is typical.</p>\n<p>How are stock-index futures trading?</p>\n<p>On Wednesday, the Dow industrials fell 9.42 points to finish nearly flat at 35,804.38. The S&P 500 slipped 0.2% to close at 4,701.46, just 0.1% below its Nov. 18 record close of 4,704.54, according to Dow Jones Market Data. The Nasdaq Composite Index rose 0.4% to 15,84.23.</p>\n<p>What's driving the market?</p>\n<p>It was an ugly day for stock investors during a thinly traded Black Friday session, which was susceptible to big swings on alarming news from public health officials who were assessing a new variant of the coronavirus that causes COVID-19.</p>\n<p>Late in the session, the World Health Organization's technical advisory group assigned the B. 1.1.529 variant of the virus the Greek letter omicron and declared it a \"variant of concern,\" as it did with the delta variant.</p>\n<p>Fear of a new variant overshadowed the usual focus on U.S. Black Friday shopping day, which puts the focus on retailers as consumers shop for bargains.</p>\n<p>Particularly notable about the variant is the \"large number of mutations, some of which are concerning,\" the WHO group said in a statement. The mutations could make omicron more resistant to the current batch of vaccines.</p>\n<p>The discovery of the new COVID strain was announced on Friday by South Africa's health minister Joe Phaahla. He said scientists were concerned because of its high number of mutations and the dramatic surge in infections the country had seen over the past four or five days.</p>\n<p>\"The pandemic and COVID variants remain <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the biggest risks to markets, and are likely to continue to inject volatility over the next year(s),\" wrote Keith Lerner, co-chief investment officer and chief market strategist at Truist Advisory Services, in a Friday note. \"It's hard to say at this point how lasting or impactful this latest variant will be for markets,\" the analyst wrote.</p>\n<p>The omicron strain has been detected in Botswana and in Hong Kong in travelers who had visited South Africa.</p>\n<p>\"The one bull in the China shop that could truly derail the global recovery has always been a new strain of Covid-19 that swept the world and caused the reimposition of mass social retractions,\" said Jeffrey Halley, senior market analyst, at OANDA, in a note. \"All we know so far is the B. 1.1.529 is heavily mutated but markets are taking no chances.\"</p>\n<p>\"Just when you thought Covid was being controlled in a holiday shortened week,\" said Sam Stovall, chief investment strategist at CFRA Research, in emailed comments.</p>\n<p>Trading around the Thanksgiving holiday is often associated with lower trading volumes as traders typically wait until Monday to return to work. There was no U.S. economic data on the calendar for Friday.</p>\n<p>After new cases stabilized at 200 a day, South Africa reported more than 1,200 on Wednesday and 2,465 on Thursday.</p>\n<p>The U.K. government is banning flights from South Africa along with five other African nations, effective Friday.</p>\n<p>\"Predictably, energy, travel related and financials are the leading decliners and treasuries are rallying,\" wrote Jay Hatfield, CEO and portfolio manager at Infrastructure Capital Management, in emailed comments on Friday.</p>\n<p>\"It makes sense to have a market significant correction given the high level of uncertainty,\" the money manager wrote.</p>\n<p>\"At this stage very little is known,\" Deutsche Bank strategists, led by Jim Reid, told clients in a note. \"Mutations are often less severe so we shouldn't jump to conclusions but there is clearly a lot of concern about this one. Also South Africa is one of the world leaders in sequencing so we are more likely to see this sort of news originate from there than many countries. Suffice to say at this stage no one in markets will have any idea which way this will go.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow plunges 905 points in Black Friday selloff, books worst day in over a year as WHO declares new COVID 'variant of concern'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow plunges 905 points in Black Friday selloff, books worst day in over a year as WHO declares new COVID 'variant of concern'\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-11-27 07:06</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dow notches worst day for blue chips since Oct. 28, 2020, FactSet data show</p>\n<p>U.S. stock benchmarks suffered withering losses on Friday as stock and commodity markets plunged, after scientists detected a new COVID variant in South Africa that could be to blame for a recent sharp surge in cases, especially in Europe.</p>\n<p>U.S. markets were closed for Thanksgiving on Thursday and ended at 1 p.m. Eastern Time on Friday, three hours earlier than usual, and bond market trading ends at 2 p.m., an hour earlier than is typical.</p>\n<p>How are stock-index futures trading?</p>\n<p>On Wednesday, the Dow industrials fell 9.42 points to finish nearly flat at 35,804.38. The S&P 500 slipped 0.2% to close at 4,701.46, just 0.1% below its Nov. 18 record close of 4,704.54, according to Dow Jones Market Data. The Nasdaq Composite Index rose 0.4% to 15,84.23.</p>\n<p>What's driving the market?</p>\n<p>It was an ugly day for stock investors during a thinly traded Black Friday session, which was susceptible to big swings on alarming news from public health officials who were assessing a new variant of the coronavirus that causes COVID-19.</p>\n<p>Late in the session, the World Health Organization's technical advisory group assigned the B. 1.1.529 variant of the virus the Greek letter omicron and declared it a \"variant of concern,\" as it did with the delta variant.</p>\n<p>Fear of a new variant overshadowed the usual focus on U.S. Black Friday shopping day, which puts the focus on retailers as consumers shop for bargains.</p>\n<p>Particularly notable about the variant is the \"large number of mutations, some of which are concerning,\" the WHO group said in a statement. The mutations could make omicron more resistant to the current batch of vaccines.</p>\n<p>The discovery of the new COVID strain was announced on Friday by South Africa's health minister Joe Phaahla. He said scientists were concerned because of its high number of mutations and the dramatic surge in infections the country had seen over the past four or five days.</p>\n<p>\"The pandemic and COVID variants remain <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the biggest risks to markets, and are likely to continue to inject volatility over the next year(s),\" wrote Keith Lerner, co-chief investment officer and chief market strategist at Truist Advisory Services, in a Friday note. \"It's hard to say at this point how lasting or impactful this latest variant will be for markets,\" the analyst wrote.</p>\n<p>The omicron strain has been detected in Botswana and in Hong Kong in travelers who had visited South Africa.</p>\n<p>\"The one bull in the China shop that could truly derail the global recovery has always been a new strain of Covid-19 that swept the world and caused the reimposition of mass social retractions,\" said Jeffrey Halley, senior market analyst, at OANDA, in a note. \"All we know so far is the B. 1.1.529 is heavily mutated but markets are taking no chances.\"</p>\n<p>\"Just when you thought Covid was being controlled in a holiday shortened week,\" said Sam Stovall, chief investment strategist at CFRA Research, in emailed comments.</p>\n<p>Trading around the Thanksgiving holiday is often associated with lower trading volumes as traders typically wait until Monday to return to work. There was no U.S. economic data on the calendar for Friday.</p>\n<p>After new cases stabilized at 200 a day, South Africa reported more than 1,200 on Wednesday and 2,465 on Thursday.</p>\n<p>The U.K. government is banning flights from South Africa along with five other African nations, effective Friday.</p>\n<p>\"Predictably, energy, travel related and financials are the leading decliners and treasuries are rallying,\" wrote Jay Hatfield, CEO and portfolio manager at Infrastructure Capital Management, in emailed comments on Friday.</p>\n<p>\"It makes sense to have a market significant correction given the high level of uncertainty,\" the money manager wrote.</p>\n<p>\"At this stage very little is known,\" Deutsche Bank strategists, led by Jim Reid, told clients in a note. \"Mutations are often less severe so we shouldn't jump to conclusions but there is clearly a lot of concern about this one. Also South Africa is one of the world leaders in sequencing so we are more likely to see this sort of news originate from there than many countries. Suffice to say at this stage no one in markets will have any idea which way this will go.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4554":"元宇宙及AR概念","BK4566":"资本集团","BK4525":"远程办公概念","BK4532":"文艺复兴科技持仓","BK4548":"巴美列捷福持仓","BK4528":"SaaS概念","BK4551":"寇图资本持仓","ZM":"Zoom","BK4535":"淡马锡持仓","PTON":"Peloton Interactive, Inc.","BK4505":"高瓴资本持仓","BK4190":"消闲用品","BK4023":"应用软件"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2186344334","content_text":"Dow notches worst day for blue chips since Oct. 28, 2020, FactSet data show\nU.S. stock benchmarks suffered withering losses on Friday as stock and commodity markets plunged, after scientists detected a new COVID variant in South Africa that could be to blame for a recent sharp surge in cases, especially in Europe.\nU.S. markets were closed for Thanksgiving on Thursday and ended at 1 p.m. Eastern Time on Friday, three hours earlier than usual, and bond market trading ends at 2 p.m., an hour earlier than is typical.\nHow are stock-index futures trading?\nOn Wednesday, the Dow industrials fell 9.42 points to finish nearly flat at 35,804.38. The S&P 500 slipped 0.2% to close at 4,701.46, just 0.1% below its Nov. 18 record close of 4,704.54, according to Dow Jones Market Data. The Nasdaq Composite Index rose 0.4% to 15,84.23.\nWhat's driving the market?\nIt was an ugly day for stock investors during a thinly traded Black Friday session, which was susceptible to big swings on alarming news from public health officials who were assessing a new variant of the coronavirus that causes COVID-19.\nLate in the session, the World Health Organization's technical advisory group assigned the B. 1.1.529 variant of the virus the Greek letter omicron and declared it a \"variant of concern,\" as it did with the delta variant.\nFear of a new variant overshadowed the usual focus on U.S. Black Friday shopping day, which puts the focus on retailers as consumers shop for bargains.\nParticularly notable about the variant is the \"large number of mutations, some of which are concerning,\" the WHO group said in a statement. The mutations could make omicron more resistant to the current batch of vaccines.\nThe discovery of the new COVID strain was announced on Friday by South Africa's health minister Joe Phaahla. He said scientists were concerned because of its high number of mutations and the dramatic surge in infections the country had seen over the past four or five days.\n\"The pandemic and COVID variants remain one of the biggest risks to markets, and are likely to continue to inject volatility over the next year(s),\" wrote Keith Lerner, co-chief investment officer and chief market strategist at Truist Advisory Services, in a Friday note. \"It's hard to say at this point how lasting or impactful this latest variant will be for markets,\" the analyst wrote.\nThe omicron strain has been detected in Botswana and in Hong Kong in travelers who had visited South Africa.\n\"The one bull in the China shop that could truly derail the global recovery has always been a new strain of Covid-19 that swept the world and caused the reimposition of mass social retractions,\" said Jeffrey Halley, senior market analyst, at OANDA, in a note. \"All we know so far is the B. 1.1.529 is heavily mutated but markets are taking no chances.\"\n\"Just when you thought Covid was being controlled in a holiday shortened week,\" said Sam Stovall, chief investment strategist at CFRA Research, in emailed comments.\nTrading around the Thanksgiving holiday is often associated with lower trading volumes as traders typically wait until Monday to return to work. There was no U.S. economic data on the calendar for Friday.\nAfter new cases stabilized at 200 a day, South Africa reported more than 1,200 on Wednesday and 2,465 on Thursday.\nThe U.K. government is banning flights from South Africa along with five other African nations, effective Friday.\n\"Predictably, energy, travel related and financials are the leading decliners and treasuries are rallying,\" wrote Jay Hatfield, CEO and portfolio manager at Infrastructure Capital Management, in emailed comments on Friday.\n\"It makes sense to have a market significant correction given the high level of uncertainty,\" the money manager wrote.\n\"At this stage very little is known,\" Deutsche Bank strategists, led by Jim Reid, told clients in a note. \"Mutations are often less severe so we shouldn't jump to conclusions but there is clearly a lot of concern about this one. Also South Africa is one of the world leaders in sequencing so we are more likely to see this sort of news originate from there than many countries. Suffice to say at this stage no one in markets will have any idea which way this will go.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":888,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879342797,"gmtCreate":1636685219229,"gmtModify":1636685325469,"author":{"id":"3573948076022422","authorId":"3573948076022422","name":"Annie12345","avatar":"https://static.tigerbbs.com/b7529e308acffa5522a9e9690d9dcae6","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573948076022422","idStr":"3573948076022422"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/879342797","repostId":"1179335408","repostType":4,"isVote":1,"tweetType":1,"viewCount":263,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604455354,"gmtCreate":1639441217413,"gmtModify":1639441217858,"author":{"id":"3573948076022422","authorId":"3573948076022422","name":"Annie12345","avatar":"https://static.tigerbbs.com/b7529e308acffa5522a9e9690d9dcae6","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573948076022422","idStr":"3573948076022422"},"themes":[],"htmlText":"Yea ","listText":"Yea ","text":"Yea","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604455354","repostId":"2191098415","repostType":2,"isVote":1,"tweetType":1,"viewCount":838,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600070576,"gmtCreate":1638023352649,"gmtModify":1638023352846,"author":{"id":"3573948076022422","authorId":"3573948076022422","name":"Annie12345","avatar":"https://static.tigerbbs.com/b7529e308acffa5522a9e9690d9dcae6","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573948076022422","idStr":"3573948076022422"},"themes":[],"htmlText":"Haiz","listText":"Haiz","text":"Haiz","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600070576","repostId":"2186344334","repostType":4,"repost":{"id":"2186344334","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1637967996,"share":"https://www.laohu8.com/m/news/2186344334?lang=&edition=full","pubTime":"2021-11-27 07:06","market":"hk","language":"en","title":"Dow plunges 905 points in Black Friday selloff, books worst day in over a year as WHO declares new COVID 'variant of concern'","url":"https://stock-news.laohu8.com/highlight/detail?id=2186344334","media":"Dow Jones","summary":"Dow notches worst day for blue chips since Oct. 28, 2020, FactSet data show\nU.S. stock benchmarks su","content":"<p>Dow notches worst day for blue chips since Oct. 28, 2020, FactSet data show</p>\n<p>U.S. stock benchmarks suffered withering losses on Friday as stock and commodity markets plunged, after scientists detected a new COVID variant in South Africa that could be to blame for a recent sharp surge in cases, especially in Europe.</p>\n<p>U.S. markets were closed for Thanksgiving on Thursday and ended at 1 p.m. Eastern Time on Friday, three hours earlier than usual, and bond market trading ends at 2 p.m., an hour earlier than is typical.</p>\n<p>How are stock-index futures trading?</p>\n<p>On Wednesday, the Dow industrials fell 9.42 points to finish nearly flat at 35,804.38. The S&P 500 slipped 0.2% to close at 4,701.46, just 0.1% below its Nov. 18 record close of 4,704.54, according to Dow Jones Market Data. The Nasdaq Composite Index rose 0.4% to 15,84.23.</p>\n<p>What's driving the market?</p>\n<p>It was an ugly day for stock investors during a thinly traded Black Friday session, which was susceptible to big swings on alarming news from public health officials who were assessing a new variant of the coronavirus that causes COVID-19.</p>\n<p>Late in the session, the World Health Organization's technical advisory group assigned the B. 1.1.529 variant of the virus the Greek letter omicron and declared it a \"variant of concern,\" as it did with the delta variant.</p>\n<p>Fear of a new variant overshadowed the usual focus on U.S. Black Friday shopping day, which puts the focus on retailers as consumers shop for bargains.</p>\n<p>Particularly notable about the variant is the \"large number of mutations, some of which are concerning,\" the WHO group said in a statement. The mutations could make omicron more resistant to the current batch of vaccines.</p>\n<p>The discovery of the new COVID strain was announced on Friday by South Africa's health minister Joe Phaahla. He said scientists were concerned because of its high number of mutations and the dramatic surge in infections the country had seen over the past four or five days.</p>\n<p>\"The pandemic and COVID variants remain <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the biggest risks to markets, and are likely to continue to inject volatility over the next year(s),\" wrote Keith Lerner, co-chief investment officer and chief market strategist at Truist Advisory Services, in a Friday note. \"It's hard to say at this point how lasting or impactful this latest variant will be for markets,\" the analyst wrote.</p>\n<p>The omicron strain has been detected in Botswana and in Hong Kong in travelers who had visited South Africa.</p>\n<p>\"The one bull in the China shop that could truly derail the global recovery has always been a new strain of Covid-19 that swept the world and caused the reimposition of mass social retractions,\" said Jeffrey Halley, senior market analyst, at OANDA, in a note. \"All we know so far is the B. 1.1.529 is heavily mutated but markets are taking no chances.\"</p>\n<p>\"Just when you thought Covid was being controlled in a holiday shortened week,\" said Sam Stovall, chief investment strategist at CFRA Research, in emailed comments.</p>\n<p>Trading around the Thanksgiving holiday is often associated with lower trading volumes as traders typically wait until Monday to return to work. There was no U.S. economic data on the calendar for Friday.</p>\n<p>After new cases stabilized at 200 a day, South Africa reported more than 1,200 on Wednesday and 2,465 on Thursday.</p>\n<p>The U.K. government is banning flights from South Africa along with five other African nations, effective Friday.</p>\n<p>\"Predictably, energy, travel related and financials are the leading decliners and treasuries are rallying,\" wrote Jay Hatfield, CEO and portfolio manager at Infrastructure Capital Management, in emailed comments on Friday.</p>\n<p>\"It makes sense to have a market significant correction given the high level of uncertainty,\" the money manager wrote.</p>\n<p>\"At this stage very little is known,\" Deutsche Bank strategists, led by Jim Reid, told clients in a note. \"Mutations are often less severe so we shouldn't jump to conclusions but there is clearly a lot of concern about this one. Also South Africa is one of the world leaders in sequencing so we are more likely to see this sort of news originate from there than many countries. Suffice to say at this stage no one in markets will have any idea which way this will go.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow plunges 905 points in Black Friday selloff, books worst day in over a year as WHO declares new COVID 'variant of concern'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow plunges 905 points in Black Friday selloff, books worst day in over a year as WHO declares new COVID 'variant of concern'\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-11-27 07:06</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dow notches worst day for blue chips since Oct. 28, 2020, FactSet data show</p>\n<p>U.S. stock benchmarks suffered withering losses on Friday as stock and commodity markets plunged, after scientists detected a new COVID variant in South Africa that could be to blame for a recent sharp surge in cases, especially in Europe.</p>\n<p>U.S. markets were closed for Thanksgiving on Thursday and ended at 1 p.m. Eastern Time on Friday, three hours earlier than usual, and bond market trading ends at 2 p.m., an hour earlier than is typical.</p>\n<p>How are stock-index futures trading?</p>\n<p>On Wednesday, the Dow industrials fell 9.42 points to finish nearly flat at 35,804.38. The S&P 500 slipped 0.2% to close at 4,701.46, just 0.1% below its Nov. 18 record close of 4,704.54, according to Dow Jones Market Data. The Nasdaq Composite Index rose 0.4% to 15,84.23.</p>\n<p>What's driving the market?</p>\n<p>It was an ugly day for stock investors during a thinly traded Black Friday session, which was susceptible to big swings on alarming news from public health officials who were assessing a new variant of the coronavirus that causes COVID-19.</p>\n<p>Late in the session, the World Health Organization's technical advisory group assigned the B. 1.1.529 variant of the virus the Greek letter omicron and declared it a \"variant of concern,\" as it did with the delta variant.</p>\n<p>Fear of a new variant overshadowed the usual focus on U.S. Black Friday shopping day, which puts the focus on retailers as consumers shop for bargains.</p>\n<p>Particularly notable about the variant is the \"large number of mutations, some of which are concerning,\" the WHO group said in a statement. The mutations could make omicron more resistant to the current batch of vaccines.</p>\n<p>The discovery of the new COVID strain was announced on Friday by South Africa's health minister Joe Phaahla. He said scientists were concerned because of its high number of mutations and the dramatic surge in infections the country had seen over the past four or five days.</p>\n<p>\"The pandemic and COVID variants remain <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the biggest risks to markets, and are likely to continue to inject volatility over the next year(s),\" wrote Keith Lerner, co-chief investment officer and chief market strategist at Truist Advisory Services, in a Friday note. \"It's hard to say at this point how lasting or impactful this latest variant will be for markets,\" the analyst wrote.</p>\n<p>The omicron strain has been detected in Botswana and in Hong Kong in travelers who had visited South Africa.</p>\n<p>\"The one bull in the China shop that could truly derail the global recovery has always been a new strain of Covid-19 that swept the world and caused the reimposition of mass social retractions,\" said Jeffrey Halley, senior market analyst, at OANDA, in a note. \"All we know so far is the B. 1.1.529 is heavily mutated but markets are taking no chances.\"</p>\n<p>\"Just when you thought Covid was being controlled in a holiday shortened week,\" said Sam Stovall, chief investment strategist at CFRA Research, in emailed comments.</p>\n<p>Trading around the Thanksgiving holiday is often associated with lower trading volumes as traders typically wait until Monday to return to work. There was no U.S. economic data on the calendar for Friday.</p>\n<p>After new cases stabilized at 200 a day, South Africa reported more than 1,200 on Wednesday and 2,465 on Thursday.</p>\n<p>The U.K. government is banning flights from South Africa along with five other African nations, effective Friday.</p>\n<p>\"Predictably, energy, travel related and financials are the leading decliners and treasuries are rallying,\" wrote Jay Hatfield, CEO and portfolio manager at Infrastructure Capital Management, in emailed comments on Friday.</p>\n<p>\"It makes sense to have a market significant correction given the high level of uncertainty,\" the money manager wrote.</p>\n<p>\"At this stage very little is known,\" Deutsche Bank strategists, led by Jim Reid, told clients in a note. \"Mutations are often less severe so we shouldn't jump to conclusions but there is clearly a lot of concern about this one. Also South Africa is one of the world leaders in sequencing so we are more likely to see this sort of news originate from there than many countries. Suffice to say at this stage no one in markets will have any idea which way this will go.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4554":"元宇宙及AR概念","BK4566":"资本集团","BK4525":"远程办公概念","BK4532":"文艺复兴科技持仓","BK4548":"巴美列捷福持仓","BK4528":"SaaS概念","BK4551":"寇图资本持仓","ZM":"Zoom","BK4535":"淡马锡持仓","PTON":"Peloton Interactive, Inc.","BK4505":"高瓴资本持仓","BK4190":"消闲用品","BK4023":"应用软件"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2186344334","content_text":"Dow notches worst day for blue chips since Oct. 28, 2020, FactSet data show\nU.S. stock benchmarks suffered withering losses on Friday as stock and commodity markets plunged, after scientists detected a new COVID variant in South Africa that could be to blame for a recent sharp surge in cases, especially in Europe.\nU.S. markets were closed for Thanksgiving on Thursday and ended at 1 p.m. Eastern Time on Friday, three hours earlier than usual, and bond market trading ends at 2 p.m., an hour earlier than is typical.\nHow are stock-index futures trading?\nOn Wednesday, the Dow industrials fell 9.42 points to finish nearly flat at 35,804.38. The S&P 500 slipped 0.2% to close at 4,701.46, just 0.1% below its Nov. 18 record close of 4,704.54, according to Dow Jones Market Data. The Nasdaq Composite Index rose 0.4% to 15,84.23.\nWhat's driving the market?\nIt was an ugly day for stock investors during a thinly traded Black Friday session, which was susceptible to big swings on alarming news from public health officials who were assessing a new variant of the coronavirus that causes COVID-19.\nLate in the session, the World Health Organization's technical advisory group assigned the B. 1.1.529 variant of the virus the Greek letter omicron and declared it a \"variant of concern,\" as it did with the delta variant.\nFear of a new variant overshadowed the usual focus on U.S. Black Friday shopping day, which puts the focus on retailers as consumers shop for bargains.\nParticularly notable about the variant is the \"large number of mutations, some of which are concerning,\" the WHO group said in a statement. The mutations could make omicron more resistant to the current batch of vaccines.\nThe discovery of the new COVID strain was announced on Friday by South Africa's health minister Joe Phaahla. He said scientists were concerned because of its high number of mutations and the dramatic surge in infections the country had seen over the past four or five days.\n\"The pandemic and COVID variants remain one of the biggest risks to markets, and are likely to continue to inject volatility over the next year(s),\" wrote Keith Lerner, co-chief investment officer and chief market strategist at Truist Advisory Services, in a Friday note. \"It's hard to say at this point how lasting or impactful this latest variant will be for markets,\" the analyst wrote.\nThe omicron strain has been detected in Botswana and in Hong Kong in travelers who had visited South Africa.\n\"The one bull in the China shop that could truly derail the global recovery has always been a new strain of Covid-19 that swept the world and caused the reimposition of mass social retractions,\" said Jeffrey Halley, senior market analyst, at OANDA, in a note. \"All we know so far is the B. 1.1.529 is heavily mutated but markets are taking no chances.\"\n\"Just when you thought Covid was being controlled in a holiday shortened week,\" said Sam Stovall, chief investment strategist at CFRA Research, in emailed comments.\nTrading around the Thanksgiving holiday is often associated with lower trading volumes as traders typically wait until Monday to return to work. There was no U.S. economic data on the calendar for Friday.\nAfter new cases stabilized at 200 a day, South Africa reported more than 1,200 on Wednesday and 2,465 on Thursday.\nThe U.K. government is banning flights from South Africa along with five other African nations, effective Friday.\n\"Predictably, energy, travel related and financials are the leading decliners and treasuries are rallying,\" wrote Jay Hatfield, CEO and portfolio manager at Infrastructure Capital Management, in emailed comments on Friday.\n\"It makes sense to have a market significant correction given the high level of uncertainty,\" the money manager wrote.\n\"At this stage very little is known,\" Deutsche Bank strategists, led by Jim Reid, told clients in a note. \"Mutations are often less severe so we shouldn't jump to conclusions but there is clearly a lot of concern about this one. Also South Africa is one of the world leaders in sequencing so we are more likely to see this sort of news originate from there than many countries. Suffice to say at this stage no one in markets will have any idea which way this will go.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":1068,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873952288,"gmtCreate":1636849821806,"gmtModify":1636849821984,"author":{"id":"3573948076022422","authorId":"3573948076022422","name":"Annie12345","avatar":"https://static.tigerbbs.com/b7529e308acffa5522a9e9690d9dcae6","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573948076022422","idStr":"3573948076022422"},"themes":[],"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873952288","repostId":"1129004768","repostType":4,"isVote":1,"tweetType":1,"viewCount":761,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872622320,"gmtCreate":1637509764766,"gmtModify":1637509764996,"author":{"id":"3573948076022422","authorId":"3573948076022422","name":"Annie12345","avatar":"https://static.tigerbbs.com/b7529e308acffa5522a9e9690d9dcae6","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573948076022422","idStr":"3573948076022422"},"themes":[],"htmlText":"Lol","listText":"Lol","text":"Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872622320","repostId":"1136453612","repostType":4,"isVote":1,"tweetType":1,"viewCount":1311,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604800763,"gmtCreate":1639364649863,"gmtModify":1639364924275,"author":{"id":"3573948076022422","authorId":"3573948076022422","name":"Annie12345","avatar":"https://static.tigerbbs.com/b7529e308acffa5522a9e9690d9dcae6","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573948076022422","idStr":"3573948076022422"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604800763","repostId":"605462650","repostType":1,"repost":{"id":605462650,"gmtCreate":1639222201797,"gmtModify":1639233253732,"author":{"id":"3569316529855154","authorId":"3569316529855154","name":"Deonc","avatar":"https://static.tigerbbs.com/d9aa45dd2eb58357f6477dcfb99d1415","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569316529855154","idStr":"3569316529855154"},"themes":[],"title":"Sea Limited drops to end week","htmlText":"Sea Limited drops to end week as Hedgeye calls it a top short idea Back view of young gamer playing video games on computerSea Limited (NYSE:SE) ended the week on a low note, dropping 6.6% today after being named as a best idea short at Hedgeye.Shares had pulled back some 30% from their all-time highs already, analyst Felix Wang notes, but says the valuation is still \"lofty\" - and has room for another 35% downside.The company is facing more competitive pressure, he says, and some of the routes forward aren't as solid as expected. Sea is looking to Brazil to support international growth, but Wang says the gaming opportunity in Brazil is \"hyped\" and e-commerce there is shaky as well.As for its flagship game Garena Free Fire, it's a \"one-hit wonder whose performance has peaked,\" with engageme","listText":"Sea Limited drops to end week as Hedgeye calls it a top short idea Back view of young gamer playing video games on computerSea Limited (NYSE:SE) ended the week on a low note, dropping 6.6% today after being named as a best idea short at Hedgeye.Shares had pulled back some 30% from their all-time highs already, analyst Felix Wang notes, but says the valuation is still \"lofty\" - and has room for another 35% downside.The company is facing more competitive pressure, he says, and some of the routes forward aren't as solid as expected. Sea is looking to Brazil to support international growth, but Wang says the gaming opportunity in Brazil is \"hyped\" and e-commerce there is shaky as well.As for its flagship game Garena Free Fire, it's a \"one-hit wonder whose performance has peaked,\" with engageme","text":"Sea Limited drops to end week as Hedgeye calls it a top short idea Back view of young gamer playing video games on computerSea Limited (NYSE:SE) ended the week on a low note, dropping 6.6% today after being named as a best idea short at Hedgeye.Shares had pulled back some 30% from their all-time highs already, analyst Felix Wang notes, but says the valuation is still \"lofty\" - and has room for another 35% downside.The company is facing more competitive pressure, he says, and some of the routes forward aren't as solid as expected. Sea is looking to Brazil to support international growth, but Wang says the gaming opportunity in Brazil is \"hyped\" and e-commerce there is shaky as well.As for its flagship game Garena Free Fire, it's a \"one-hit wonder whose performance has peaked,\" with engageme","images":[],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605462650","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1121,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604800494,"gmtCreate":1639364635421,"gmtModify":1639364923690,"author":{"id":"3573948076022422","authorId":"3573948076022422","name":"Annie12345","avatar":"https://static.tigerbbs.com/b7529e308acffa5522a9e9690d9dcae6","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573948076022422","idStr":"3573948076022422"},"themes":[],"htmlText":"O","listText":"O","text":"O","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604800494","repostId":"605477626","repostType":1,"repost":{"id":605477626,"gmtCreate":1639236121452,"gmtModify":1639399159414,"author":{"id":"3548388348794551","authorId":"3548388348794551","name":"问就是加仓up","avatar":"https://static.tigerbbs.com/4e98ddf789d46c5627f944fc581c0fe9","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3548388348794551","idStr":"3548388348794551"},"themes":[],"title":"2021年复盘:大赚到接近清零,回本绝对是最浪漫的事","htmlText":"又到了年底复盘的时候,今年炒股体验真的极度复杂,年初觉得自己是股神, 年中觉得自己是韭菜,年底两个月又觉得自己能行了。这一年心路历程不是一篇帖子能够描述的,但还是希望通过年度复盘给大家还原一些比较有意义的观点。 这是去年的复盘链接 <a href=\"https://laohu8.com/TW/331834662\" target=\"_blank\">2020总结:美股10倍,港股2倍,A股:赚钱是甚么</a> 今年的复盘主要分5个部分,收益复盘,操作复盘,一些感悟,交易手法,未来展望。文章有点长,可以直接跳转看自己感兴趣的部分。 1,收益:勉强保本 今年账户保本小赚,年中的时候一度大亏,在10月份开始飞速回本了,之后一路操作很多,但是也没啥大的收益。至于说收益图基本上也没法看,因为今年出入金频率太高,曲线都是-99%,因为中途出现过账户暴跌。但是由于控制了账户资金,没有受伤很严重。 这个图是12月10日截图,截止到今天一共交易了470w美金,交易频率比较高。累计交易了205只,其中盈利的只有43只,基本上就是赚钱的拿得住,赔钱的跑得快,当然也因此卖飞了不少股票。截止到今天一共挣了1600刀,收益率多少,我也不知道,根本算不出来。 另外今年开了N多的账户打新(几十个),这也是资金进出频繁的一个原因,不过这些账户都是亏钱出局,4月份之后基本上不打新了,打新是今年的一个重要亏损点。如果把所有账户加起来,今年基本上没赚钱,因为还有一个大账户也小有盈利,差不多可以把各种打野的亏损平衡掉。 2,操作复盘 每个月都有一些神之操作,每个月都有不一样的槽点。文中的时间节点可能记得不是那么清晰,相关操作之前发帖子也有提过,主要说一些印象比较深刻的。 1月份 中概股暴涨完整的吃到了,而且这也是账户高频交易的开始,当时买老虎股票,从6美金涨到了38美金(环球账户被清空了,没法晒)","listText":"又到了年底复盘的时候,今年炒股体验真的极度复杂,年初觉得自己是股神, 年中觉得自己是韭菜,年底两个月又觉得自己能行了。这一年心路历程不是一篇帖子能够描述的,但还是希望通过年度复盘给大家还原一些比较有意义的观点。 这是去年的复盘链接 <a href=\"https://laohu8.com/TW/331834662\" target=\"_blank\">2020总结:美股10倍,港股2倍,A股:赚钱是甚么</a> 今年的复盘主要分5个部分,收益复盘,操作复盘,一些感悟,交易手法,未来展望。文章有点长,可以直接跳转看自己感兴趣的部分。 1,收益:勉强保本 今年账户保本小赚,年中的时候一度大亏,在10月份开始飞速回本了,之后一路操作很多,但是也没啥大的收益。至于说收益图基本上也没法看,因为今年出入金频率太高,曲线都是-99%,因为中途出现过账户暴跌。但是由于控制了账户资金,没有受伤很严重。 这个图是12月10日截图,截止到今天一共交易了470w美金,交易频率比较高。累计交易了205只,其中盈利的只有43只,基本上就是赚钱的拿得住,赔钱的跑得快,当然也因此卖飞了不少股票。截止到今天一共挣了1600刀,收益率多少,我也不知道,根本算不出来。 另外今年开了N多的账户打新(几十个),这也是资金进出频繁的一个原因,不过这些账户都是亏钱出局,4月份之后基本上不打新了,打新是今年的一个重要亏损点。如果把所有账户加起来,今年基本上没赚钱,因为还有一个大账户也小有盈利,差不多可以把各种打野的亏损平衡掉。 2,操作复盘 每个月都有一些神之操作,每个月都有不一样的槽点。文中的时间节点可能记得不是那么清晰,相关操作之前发帖子也有提过,主要说一些印象比较深刻的。 1月份 中概股暴涨完整的吃到了,而且这也是账户高频交易的开始,当时买老虎股票,从6美金涨到了38美金(环球账户被清空了,没法晒)","text":"又到了年底复盘的时候,今年炒股体验真的极度复杂,年初觉得自己是股神, 年中觉得自己是韭菜,年底两个月又觉得自己能行了。这一年心路历程不是一篇帖子能够描述的,但还是希望通过年度复盘给大家还原一些比较有意义的观点。 这是去年的复盘链接 2020总结:美股10倍,港股2倍,A股:赚钱是甚么 今年的复盘主要分5个部分,收益复盘,操作复盘,一些感悟,交易手法,未来展望。文章有点长,可以直接跳转看自己感兴趣的部分。 1,收益:勉强保本 今年账户保本小赚,年中的时候一度大亏,在10月份开始飞速回本了,之后一路操作很多,但是也没啥大的收益。至于说收益图基本上也没法看,因为今年出入金频率太高,曲线都是-99%,因为中途出现过账户暴跌。但是由于控制了账户资金,没有受伤很严重。 这个图是12月10日截图,截止到今天一共交易了470w美金,交易频率比较高。累计交易了205只,其中盈利的只有43只,基本上就是赚钱的拿得住,赔钱的跑得快,当然也因此卖飞了不少股票。截止到今天一共挣了1600刀,收益率多少,我也不知道,根本算不出来。 另外今年开了N多的账户打新(几十个),这也是资金进出频繁的一个原因,不过这些账户都是亏钱出局,4月份之后基本上不打新了,打新是今年的一个重要亏损点。如果把所有账户加起来,今年基本上没赚钱,因为还有一个大账户也小有盈利,差不多可以把各种打野的亏损平衡掉。 2,操作复盘 每个月都有一些神之操作,每个月都有不一样的槽点。文中的时间节点可能记得不是那么清晰,相关操作之前发帖子也有提过,主要说一些印象比较深刻的。 1月份 中概股暴涨完整的吃到了,而且这也是账户高频交易的开始,当时买老虎股票,从6美金涨到了38美金(环球账户被清空了,没法晒)","images":[{"img":"https://static.tigerbbs.com/fad4be5c0b8c595847d68aaeb0d403c7","width":"-1","height":"-1"},{"img":"https://static.tigerbbs.com/b997c7eb8dab40ed1a413c3502e16b53","width":"-1","height":"-1"},{"img":"https://static.tigerbbs.com/ccf5b3b2ff1b8703b1e8a4f1dfac346c","width":"-1","height":"-1"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605477626","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":16,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":780,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600079187,"gmtCreate":1638023420408,"gmtModify":1638023420654,"author":{"id":"3573948076022422","authorId":"3573948076022422","name":"Annie12345","avatar":"https://static.tigerbbs.com/b7529e308acffa5522a9e9690d9dcae6","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573948076022422","idStr":"3573948076022422"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600079187","repostId":"875206593","repostType":1,"repost":{"id":875206593,"gmtCreate":1637653011508,"gmtModify":1637923972899,"author":{"id":"3585780691540522","authorId":"3585780691540522","name":"FundMall","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585780691540522","idStr":"3585780691540522"},"themes":[],"title":"Fund College: When should you take profit?","htmlText":"One pertinent question investors commonly ask themselves is: ‘when should I take profits?’. This is no doubt a tough question to answer since we as investors are always seeking higher returns from our investments. In today’s article, we will break down our thoughts on this topic for our platform’s investors. To begin with, there is nothing wrong with chasing more returns despite having your investments in the green. However, we think that it is a good practice to review your portfolio at the end of the year or even the start of the year, even if you have a time horizon of ten years or more, given that sometimes a certain investment may become a huge part in your portfolio, especially if it has rallied aggressively. Take for example you have invested in the technology sector during the Covi","listText":"One pertinent question investors commonly ask themselves is: ‘when should I take profits?’. This is no doubt a tough question to answer since we as investors are always seeking higher returns from our investments. In today’s article, we will break down our thoughts on this topic for our platform’s investors. To begin with, there is nothing wrong with chasing more returns despite having your investments in the green. However, we think that it is a good practice to review your portfolio at the end of the year or even the start of the year, even if you have a time horizon of ten years or more, given that sometimes a certain investment may become a huge part in your portfolio, especially if it has rallied aggressively. Take for example you have invested in the technology sector during the Covi","text":"One pertinent question investors commonly ask themselves is: ‘when should I take profits?’. This is no doubt a tough question to answer since we as investors are always seeking higher returns from our investments. In today’s article, we will break down our thoughts on this topic for our platform’s investors. To begin with, there is nothing wrong with chasing more returns despite having your investments in the green. However, we think that it is a good practice to review your portfolio at the end of the year or even the start of the year, even if you have a time horizon of ten years or more, given that sometimes a certain investment may become a huge part in your portfolio, especially if it has rallied aggressively. Take for example you have invested in the technology sector during the Covi","images":[],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875206593","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":788,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}